cid,link,name,Synonyms,MOA
459803,https://pubchem.ncbi.nlm.nih.gov/compound/459803,AC1LA18U,,Inhibitor of the HIF prolyl 4-hydroxylase
91899426,https://pubchem.ncbi.nlm.nih.gov/compound/91899426,2-phospho-L-ascorbic acid,2-phospho-L-ascorbic acid;BDBM92477,_
286003,https://pubchem.ncbi.nlm.nih.gov/compound/286003,DTXSID80301486,,Agonist of the Adenosine Receptor
47289,https://pubchem.ncbi.nlm.nih.gov/compound/47289,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone,,_
451668,https://pubchem.ncbi.nlm.nih.gov/compound/451668,5-Aza-2'-deoxycytidine,"Decitabine;5-Aza-2'-deoxycytidine;2353-33-5;Dacogen;5-Azadeoxycytidine;2'-Deoxy-5-azacytidine;AzadC;5-aza-CdR;Dezocitidine;5-aza-dC;NSC 127716;5-aza-2-deoxycytidine;UNII-776B62CQ27;5A2dc;4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one;Dac;4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one;4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;MLS001332587;CHEBI:50131;4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one;776B62CQ27;SMR000857076;2-Desoxy-5-azacytidine;4-Amino-1-(2-deoxy-beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;NSC-127716;DSSTox_CID_10432;DSSTox_RID_78849;DSSTox_GSID_30432;Decitabine [USAN:INN:BAN];Alpha-Decitibine;C8H12N4O4;5-Aza-2'-deoxycytidine, 98%;5-AZAdC;EINECS 219-089-4;NSC127716;2-deoxyazacytidine;4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,3,5-triazin-2-one;BRN 0617982;Dacogen (TN);CAS-2353-33-5;5-Aza-deoxycytidine;NCGC_5ADOC;Decitabine (USAN/INN);5-Deoxy-2&prime;-azacytidine;5-Aza-2&prime;-Deoxycytidine;CCRIS 8227;4-amino-1-(2-deoxy-beta-d-erythro-pentofuranosyl)-s-triazin-2(1h)-on;NCGC00166088-01;deoxy-5-azacytidine;Decitabine, Free Base;PubChem19115;JNJ 30979754;JNJ-30979754;MolMap_000063;E-7373;SCHEMBL4006;cc-571;MLS001332588;MLS006010136;BIFK0051;cid_451668;EOS114;GTPL6805;CHEMBL1201129;DTXSID7030432;s-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-;BDBM96274;CTK1A2018;EX-A961;SYN3036;1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-;XAUDJQYHKZQPEU-KVQBGUIXSA-N;HMS2235O03;HMS3413L07;HMS3677L07;22432-95-7;ACT00147;BCP02870;HY-A0004;5-Aza-2'-deoxycytidine, >=97%;Tox21_112311;ABP001084;ANW-25144;MFCD00043011;s1200;ZINC16929327;4-Amino-1-(2-deoxy-?-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;AKOS015895047;Tox21_112311_1;AC-1135;API0002229;BCP9000593;CCG-208143;CS-0372;DB01262;SB18982;Decitabine (NSC127716, 5AZA-CdR);NCGC00166088-02;NCGC00166088-05;AS-17558;CC-26303;SC-19951;BCP0726000271;AB0020011;DB-029060;SW218076-2;V0702;D03665;J10097;W-5049;AB00918337-07;AB00918337_08;353A335;C-13049;SR-01000838879;J-700084;Q1181878;SR-01000838879-4;decitabine (2 inverted exclamation marka-deoxy-5-azacytidine).cd;4-amino-1-(2-deoxy-ss-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;1,3, 5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy--D-erythro-pentofuranosyl)-;4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one",Inhibitor of DNA methylation
16218924,https://pubchem.ncbi.nlm.nih.gov/compound/16218924,A83-01,"909910-43-6;A 83-01;A-83-01;3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide;A83-01;TGF-beta inhibitor A-83-01;C25H19N5S;3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide;1H-Pyrazole-1-carbothioamide,3-(6-methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-;J-504722;ALK5 Inhibitor IV;TGFss inhibitor A-83-01;cc-656;SCHEMBL142081;CHEMBL1170377;CTK8E7450;KS-00001CSC;AOB1090;DTXSID60585065;EX-A482;SYN5149;BCP05991;BS0251;Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor IV;ZINC13829336;3-(6-Methylpyridin-2-yl)-4-(4-quinolyl)-1-phenylthiocarbamoyl-1H-pyrazole;AKOS024457346;CS-1437;3-(6-methyl-2-pyridinyl)-n-phenyl-4-(4-quinolinyl)-1h-pyrazole-1-carbothioamide;NCGC00165721-01;NCGC00165721-02;NCGC00165721-16;4CA-0094;AS-16512;DA-35362;HY-10432;QC-11721;FT-0746646;Y1245;EC-000.2376;A12358;W-5384;Q26998219;3-(6-Methyl-2-pyridinyl)-N-phenyl-4 -(4-quinolinyl)-1H-pyrazole-1-carbothioamide;3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothio amide;3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-yl-1H-pyrazole-1-carbothioamide","Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases)"
60961,https://pubchem.ncbi.nlm.nih.gov/compound/60961,Adenosine,,Osteogenic inducer
2051,https://pubchem.ncbi.nlm.nih.gov/compound/2051,AG-1478,,Inhibitor of the epidermal growth factor receptor
2126,https://pubchem.ncbi.nlm.nih.gov/compound/2126,AM580,"AM580;102121-60-8;Am 580;AM-580;Ro 40-6055;CD-336;CD 336;4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamido)benzoic acid;UNII-VZ5S5G9ZFZ;4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid;Ro-40-6055;VZ5S5G9ZFZ;BRN 3565084;CHEMBL69367;CHEBI:64210;NSC608001;Benzoic acid,4-[[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl]amino]-;4-((5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl)aminobenzoic acid;4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid;Benzoic acid, 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl)amino-;SR-01000597463;SZWKGOZKRMMLAJ-UHFFFAOYSA-N;Ro406055;ACMC-20cewx;Tocris-0760;Spectrum5_001941;4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-carbonyl)amino]benzoic acid;DSSTox_CID_20758;DSSTox_RID_79590;CBiol_001850;DSSTox_GSID_40758;BSPBio_001527;KBioGR_000247;KBioSS_000247;SCHEMBL726740;BML2-E09;GTPL2647;DTXSID5040758;CTK4A0696;KBio2_000247;KBio2_002815;KBio2_005383;KBio3_000493;KBio3_000494;AOB5264;EX-A843;BCPP000411;Bio1_000136;Bio1_000625;Bio1_001114;Bio2_000247;Bio2_000727;CD336;HMS1361M09;HMS1791M09;HMS1989M09;HMS3266B10;HMS3402M09;HMS3411H13;HMS3675H13;BCP03051;KS-00000PC3;ZINC3784077;Tox21_300780;3437AH;BDBM50052414;BN0066;MFCD00673916;s2933;AKOS024458635;API0008429;BCP9000281;CS-3251;NSC 608001;NSC-608001;4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl]amino]benzoic acid;IDI1_033997;NCGC00024774-01;NCGC00024774-02;NCGC00024774-03;NCGC00024774-04;NCGC00024774-05;NCGC00024774-06;NCGC00024774-07;NCGC00254684-01;4CA-0061;AK206372;AM580, >=98% (HPLC);AS-16835;DA-21728;HY-10475;LS-38310;NCI60_004717;BCP0726000221;CAS-102121-60-8;FT-0738259;C15619;J-000631;SR-01000597463-1;SR-01000597463-3;BRD-K06854232-001-02-5;Q27088586;4-[(1,1,4,4-tetramethyltetralin-6-carbonyl)amino]benzoic acid;4-(((5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)carbonyl)amino)benzoic acid;4-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene-7-carboxamido)benzoic acid;4-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydronaphthalene-2-Carbox Amido)Benzoic Acid;4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene-2-carboxamido)benzoic acid;4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-naphthalene-2-carbonyl)-amino]-benzoic acid;4-[(5,5,8,8-tetramethyl6,7-dihydronaphthalene-2-carbonyl)amino]benzoic acid;Benzoic acid,5',8',8'-tetramethyl-5',6',7',8'-tetrahydro-2'- naphthyl)amino)-:;Benzoic acid, 4((5',5',8',8'-tetramethyl-5',6',7', 8'-tetrahydro-2'- naphthyl)amino)-:;Benzoic acid, 4-[[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl]amino]-;EQN",Agonist of the retinoic acid receptor
9810212,https://pubchem.ncbi.nlm.nih.gov/compound/9810212,AMI5,,Inhibitor of the TGFβ pathway
135400486,https://pubchem.ncbi.nlm.nih.gov/compound/135400486,AS8351,"796-42-9;AS8351;AS-8351;N'-[(2-hydroxy-1-naphthyl)methylene]isonicotinohydrazide;(e)-n'-((2-hydroxynaphthalen-1-yl)methylene)isonicotinohydrazide;NSC51355;N'-[(2-hydroxynaphthalen-1-yl)methylidene]pyridine-4-carbohydrazide;SCHEMBL800974;CHEMBL390195;s5772;STK037070;ZINC16525821;AKOS001279162;CS-7838;MCULE-5009226404;NE57591;ST009583;AS8351, >=98% (HPLC);HY-100744;EN300-55000;A16371;2-Hydroxy-1 Naphthylaldehydeisonicotinoyl Hydrazone;2- HYDROXY-1-NAPHTHALDEHYDE-ISONICOTINOYLHYDRAZONE;Isonicotinic acid, [(2-hydroxy-1-naphthalenyl)methylene]hydrazide;N-[(1E)-2-(2-hydroxynaphthyl)-1-azavinyl]-4-pyridylcarboxamide;N-[(E)-(2-hydroxy-1-naphthyl)methyleneamino]pyridine-4-carboxamide;N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]pyridine-4-carbohydrazide;N'~4~-[(E)-1-(2-hydroxy-1-naphthyl)methylidene]isonicotinohydrazide;329183-01-9",Inhibit of the histone demethylase KDM5B
25099184,https://pubchem.ncbi.nlm.nih.gov/compound/25099184,AZ 960,,Inhibitor of JAK2
2303,https://pubchem.ncbi.nlm.nih.gov/compound/2303,Bay k 8644,"71145-03-4;Bay K 8644;(�)-BAY K 8644;BAY-K-8644;methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate;BayK8644;BAYK 8644;Bay K8644;C16H15F3N2O4;MLS000028858;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester;(�)-Bay K8644;Bay-K-8644 (S)-(-)-;SMR000058424;Methyl 2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylate;1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-3-pyridinecarboxylic acid, methyl ester;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-, methyl ester;SR-01000075305;methyl (4S)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate;CHEMBL283013;BAY K-8644;Bay-K-8644 (R)-()-;Bay-K-8644, (+)-Isomer;R()-BAY K 8644;Opera_ID_789;CBiol_001744;Lopac0_000186;BSPBio_001578;MLS001148586;MLS002153190;SCHEMBL133106;(y)-Bay K 8644;GTPL2511;CHEMBL1322959;SCHEMBL14612812;CHEBI:34555;CTK2H8725;DTXSID00913080;CHEBI:131345;BAY-R 4407;BAY-R 5417;Bio1_000030;Bio1_000519;Bio1_001008;HMS1791O20;HMS1989O20;HMS2231A11;HMS2232B12;HMS3260F13;HMS3268C13;HMS3370M19;HMS3371N20;HMS3402O20;HMS3412J07;HMS3676J07;(?)-Bay K 8644;AOB33740;BCP15942;BCP23924;BCP24795;EX-A3340;KS-000018EV;Tox21_500186;BDBM50035800;BN0100;CA-410;HSCI1_000381;s7924;STL213543;AKOS015858973;(�)-BAYK8644;CCG-204281;LP00186;MCULE-8564076696;SDCCGSBI-0050174.P002;3-pyridine carboxylic acid methyl ester;( inverted question mark)-Bay K 8644;NCGC00015124-03;NCGC00015124-04;NCGC00015124-05;NCGC00015124-06;NCGC00015124-07;NCGC00015124-08;NCGC00025209-02;NCGC00025209-03;NCGC00025209-04;NCGC00025209-05;NCGC00025209-06;NCGC00260871-01;1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2&prime;-(trifluoromethyl)phenyl]-3-pyridinecarboxylic Acid Methyl Ester;AK548173;AS-16745;SMR001230679;(�)-BAY K-8644;(�)-BAY-K-8644;NCG-C00025209-02;DS-017737;LS-178346;LS-184293;AM20080536;B-112;EU-0100186;FT-0742944;(�)-Bay K8644, calcium channel agonist;BAY K 8644, (�)-;C13758;Q4874027;SR-01000075305-1;SR-01000075305-3;BRD-A05457250-001-03-5;BRD-A05457250-001-04-3;1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-;BAYK 8644; BAYK8644; BAYK-8644;Bay K8644;Bay K 8644;(S)-2,6-Dimethyl-5-nitro-4-(2-trifluoromethyl-phenyl)-1,4-dihydro-pyridine-3-carboxylic acid methyl ester;3-Pyridinecarboxylic acid,1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-,methyl ester;93468-89-4",Inhibitor of the L-type calcium channel
82146,https://pubchem.ncbi.nlm.nih.gov/compound/82146,Bexarotene,"Bexarotene;153559-49-0;Targretin;Targrexin;Targretyn;LGD 1069;LGD1069;Bexaroten;LG100069;LGD-1069;UNII-A61RXM4375;LG 1069;HSDB 7453;4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid;p-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]benzoic acid;166175-31-1;CHEMBL1023;LG 100069;LG-100069;Targret;CHEBI:50859;A61RXM4375;4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid;4-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid;NCGC00181016-01;AK-64115;SR 11247;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl]benzoic acid;4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid;DSSTox_CID_20619;DSSTox_RID_79514;DSSTox_GSID_40619;Bexarotene [USAN];bexaroteno;bexarotenum;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-vinyl]-benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-vinyl]benzoic acid;Benzoic acid, 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)-;Targretin (TN);CAS-153559-49-0;SR-05000001480;Bexarotene [USAN:INN:BAN];LG 69;LG1069;Ro 26-4455;4k6i;Bexarotene oral(targretin);SCHEMBL9025;BIDD:PXR0021;cc-197;MLS006010146;Bexarotene (JAN/USAN/INN);GTPL2807;Bexarotene, >=98% (HPLC);DTXSID1040619;CTK8E7385;AOB1247;QCR-117;NAVMQTYZDKMPEU-UHFFFAOYSA-N;HMS2089L14;HMS3655D19;HMS3747C21;4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid;ACT03911;BCP04099;KS-00000NW6;ZINC1539579;Tox21_112666;Tox21_302407;BDBM50032675;BG0619;DL-298;MFCD00932428;NSC747528;s2098;AKOS015902814;Tox21_112666_1;BCP9000396;CCG-221823;CS-0626;DB00307;MCULE-3783114634;NSC-747528;SB17341;SS-4628;4-[1-3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthaleneyl)vinyl]benzene carboxylic acid;NCGC00181016-02;NCGC00181016-03;NCGC00181016-04;NCGC00181016-08;NCGC00255426-01;AC-24569;AT-22934;HY-14171;LS-38306;SC-19638;SC-50515;SMR001614557;BCP0726000106;AB0009892;FT-0657110;FT-0702645;SW203810-3;D03106;W-5228;42161-EP2295426A1;42161-EP2295427A1;42161-EP2298768A1;42161-EP2308861A1;42161-EP2311808A1;42161-EP2311829A1;42161-EP2311840A1;AB01275475-01;AB01275475_02;559B490;A809441;Q418192;J-009026;J-519847;SR-05000001480-1;SR-05000001480-2;BRD-K92441787-001-02-5;4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid;4-[1-(5,6,7,8-TETRAHYDRO-3,5,5,8,8-PENTAMETHYL-2-N;4-[1-(3,5,5,8,8-Pentamethyl-2-5,8-dihydronaphthyl)vinyl]benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl]benzoic acid;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-vinyl]benzoic acid;4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid;4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-ethenyl]benzoic acid;Benzoic acid,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-",Activator of the retinoid X receptors
448949,https://pubchem.ncbi.nlm.nih.gov/compound/448949,BIO,"667463-62-9;BIO;GSK-3 Inhibitor IX;6-BROMOINDIRUBIN-3'-OXIME;6-bromoindirubin-3-oxime;6BIO;6-BIO;GSK 3 Inhibitor IX;(2'Z,3'E)-6-Bromoindirubin-3'-oxime;GSK-3 Inhibitor IX (BIO);(2Z,3E)-6-Bromoindirubin-3'-oxime;CHEBI:86290;(3E)-6'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-OXIME;(2Z,3E)-6'-bromo-2,3'-biindole-2',3(1H,1'H)-dione 3-oxime;BRW;C16H10BrN3O2;6-bromo-3-[3-(hydroxyamino)-2-indolylidene]-1H-indol-2-one;2H-Indol-2-one,6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-,(3Z)-;InSolution&trade; GSK-3 Inhibitor IX;1uv5;6-bromo-indirubin-3'oxime;BIO; 6-BIO;6-bromoindirubin-3''-oxime;2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-;MLS001074886;SCHEMBL470802;CHEMBL355496;GTPL5974;SCHEMBL4997980;SCHEMBL8246737;(2&prime;Z,3&prime;E)-6-Bromoindirubin-3&prime;-oxime;CHEMBL2178734;SCHEMBL14088703;SCHEMBL15565919;SCHEMBL21067440;CHEBI:91343;CTK8E9656;AOB4191;DTXSID60648023;EX-A689;HMS2230G20;HMS3229G18;HMS3262K08;HMS3265E19;HMS3265E20;HMS3265F19;HMS3265F20;HMS3374K01;HMS3413H16;HMS3648C22;HMS3653G17;HMS3677H16;BCP07234;BIO, >=98% (HPLC);Tox21_500773;(3Z)-6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1H-indol-2-one;2268AH;BDBM50012188;BDBM50191406;GL6265;HSCI1_000232;MFCD08705318;NSC737347;NSC745931;s7198;ZINC18128386;ZINC18128389;AKOS024457468;AKOS026750263;AKOS030238964;AKOS032947350;ZINC100469404;ZINC100493712;CCG-101292;CCG-208082;CS-3360;DB03444;LP00773;NSC-737347;NSC-745931;SDCCGSBI-0633754.P001;NCGC00094112-01;NCGC00094112-02;NCGC00094112-03;NCGC00094112-04;NCGC00094112-06;NCGC00261458-01;4CA-0280;AK176375;AS-55790;DA-33591;HY-10580;SMR000568408;B4006;SW219792-1;KS-00001549;K00001;MLS-0388607.0001;SR-01000838093;6BIO;GSK 3 IX;GSK 3 Inhibitor IX;MLS 2052;SR-01000838093-3;Q27077902;Q27094369;Q27163220;(Z)-6'-Bromo-1H,1'H-[2,3']biindolylidene-3,2'-dione 3-oxime;(2E,3E)-6'-bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one;(2Z,3E)-6'-Bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one;(3Z)-6-Bromo-3-[(3E)-3-hydroxyimino-1H-indol-2-ylidene]-1H-indol-2-one;(3Z)-6-bromo-3-[(3E)-3-hydroxyiminoindolin-2-ylidene]indolin-2-one;(Z)-6''-Bromo-1H,1''H-[2,3'']biindolylidene-3,2''-dione 3-oxime;6-Bromo-3-[3-(hydroxyamino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one;6-bromo-3-[3-(hydroxyamino)-2H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one;6-Bromo-3-[3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one;6-bromo-3-[3-(hydroxyimino)-2,3-dihydro-1h-indol-2-ylidene]-2,3-dihydro-1h-indol-2-one;(3Z)-6-bromo-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one",Inhibitor of GSK3
25150857,https://pubchem.ncbi.nlm.nih.gov/compound/25150857,BIX01294,"BIX-01294;935693-62-2;BIX01294;N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine;CHEMBL569864;SCHEMBL366593;GTPL7014;CHEBI:93986;AOB4774;EX-A698;C28H38N6O2;HMS3426K09;HMS3742K21;BCP06426;KS-00000T3R;BDBM50300028;ZINC36382102;AKOS015994529;AF-0051;CS-0894;SB19044;SDCCGSBI-0633794.P001;NCGC00185850-01;NCGC00185850-02;NCGC00185850-03;4-Quinazolinamine, 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-p;AK174242;DA-40377;HY-10587;BIX-01294; BIX 01294;FT-0699828;X3565;A11763;W-5578;BRD-K26818574-001-01-4;Q27075320;N-(1-benzyl-4-piperidyl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine;4-Quinazolinamine, 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-;BIX 01294, 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride;Q4A",Inhibitor of the G9a histone methyltransferase
53789347,https://pubchem.ncbi.nlm.nih.gov/substance/53789347,BML210,,Inhibitor of the HDAC
1080352,https://pubchem.ncbi.nlm.nih.gov/compound/1080352,BRD7389,"376382-11-5;BRD 7389;BRD7389;BAS 05532738;BRD-7389;LSM-4550;1-[(2-phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione;ChemDiv3_007227;Oprea1_487649;CHEMBL4303592;SCHEMBL21461689;CHEBI:93967;CTK8F0265;DTXSID90360120;HMS1493I11;ZINC794937;STK874273;AKOS000594176;CCG-120899;MCULE-4982114754;IDI1_025137;NCGC00177846-03;HY-12185;CS-0003144;BRD-K15107389-001-01-0;Q27165722","Inhibitor of the RSK1, RSK2, and RSK3"
23891512,https://pubchem.ncbi.nlm.nih.gov/compound/23891512,BRD7552,"BRD7552;1137359-47-7;BRD 7552;PK04Pur_000261;AOB2459;EX-A2283;ZINC95798323;AKOS024458540;CCG-270395;CS-5345;NCGC00170412-01;HY-19694;BRD7552, >=98% (HPLC);S7363;PK04_094072;A14957;BRD-K72827552-001-02-2;1040E1_000045;alpha-D-Glucopyranoside, methyl, 2,3-bis(N-1,3-benzodioxol-5-ylcarbamate) 4-[N-[4-(ethoxycarbonyl)phenyl]carbamate];Ethyl 4-(((((2R,3R,4S,5R,6S)-4,5-bis((benzo[d][1,3]dioxol-5-ylcarbamoyl)oxy)-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3-yl)oxy)carbonyl)amino)benzoate;Methyl [2,3-O-bis(Benzo[1,3]dioxol-5-yl-carbamoyl)]-4-O-(4-ethoxycarbonyl-phenylcarbamoyl)-?-D-glucopyranoside",Increase PDX1 promoter methylation at H3K4me3 (mark of active chromatin) and decrease H3K9me3 methylation (repressive mark)
9687,https://pubchem.ncbi.nlm.nih.gov/compound/9687,Bucladesine,,CAMP pathway activator
264,https://pubchem.ncbi.nlm.nih.gov/compound/264,Butyric acid,,_
512282,https://pubchem.ncbi.nlm.nih.gov/compound/512282,BX471,,Inhibitor of the CCR1
5943,https://pubchem.ncbi.nlm.nih.gov/compound/5943,Carbon tetrachloride,,_
11345983,https://pubchem.ncbi.nlm.nih.gov/compound/11345983,Cardiogenol C,"Cardiogenol C;671225-39-1;Ethanol, 2-[[2-[(4-methoxyphenyl)amino]-4-pyrimidinyl]amino]-;Cardiogenol;Cardiogenol C HCl;2-(2-(4-methoxyphenylamino)pyrimidin-4-ylamino)ethanol hydrochloride;2-[[2-(4-methoxyanilino)-4-pyrimidinyl]amino]ethanol;2-((2-((4-Methoxyphenyl)amino)pyrimidin-4-yl)amino)ethanol;SCHEMBL8286309;2-(4-Methoxyanilino)-4-(1-hydroxyethylamino)pyrimidine;CHEMBL1241078;BCBcMAP01_000249;CHEBI:93736;CTK8F8472;LKBSMPFEKIBRGC-UHFFFAOYSA-N;BCP16146;HSCI1_000039;ZINC13829356;AKOS015994753;API0007906;NCGC00165770-01;NCGC00165770-03;AS-47675;HY-12319;CS-0011058;BRD-K99174507-001-01-6;Q27165429;2-[[2-[(4-Methoxyphenyl)amino]-4-pyrimidinyl]amino]ethanol;2-({2-[(4-methoxyphenyl)amino]pyrimidin-4-yl}amino)ethan-1-ol",Inducer of cardiac differentiation
2662,https://pubchem.ncbi.nlm.nih.gov/compound/2662,Celecoxib,"celecoxib;169590-42-5;Celebrex;Celebra;Onsenal;Celocoxib;Celecox;SC 58635;SC-58635;4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE;YM177;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;YM 177;184007-95-2;HSDB 7038;UNII-JCX84Q7J1L;p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide;SC58635;C17H14F3N3O2S;4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide;MFCD00941298;YM-177;CHEMBL118;JCX84Q7J1L;CHEBI:41423;RZEKVGVHFLEQIL-UHFFFAOYSA-N;NCGC00091455-01;Xilebao;DSSTox_CID_2777;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide;benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;DSSTox_RID_76725;DSSTox_GSID_22777;Celecoxib [USAN];Celecoxi;Solexa;Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-;Celebrex (TN);SMR000550473;CAS-169590-42-5;SR-01000837528;Celecoxib (SC-58635);Celecoxibum;Celecoxib [USAN:INN:BAN];CCRIS 9330;TPI-336;Onsenal (TN);AI-525;CEP-33222;CELEBCOXIB;Spectrum_000432;1oq5;Spectrum2_001576;Spectrum3_001996;Spectrum4_000182;Spectrum5_001324;SC-58553, SC-58635;Celecoxib/Celebrex, Celebra;cid_2662;SCHEMBL3708;Celecoxib (JAN/USP/INN);DFN15;BSPBio_003596;KBioGR_000723;KBioGR_002351;KBioSS_000912;KBioSS_002354;cc-518;MLS001165684;MLS001195656;MLS001304708;MLS006011862;BIDD:GT0408;DivK1c_000893;SPECTRUM1503678;SPBio_001512;DFN-15;GTPL2892;Celecoxib, >=98% (HPLC);DTXSID0022777;BDBM11639;CTK8H4475;HMS502M15;KBio1_000893;KBio2_000912;KBio2_002351;KBio2_003480;KBio2_004919;KBio2_006048;KBio2_007487;KBio3_002830;KBio3_003037;EX-A175;SYN3015;cMAP_000027;NINDS_000893;BCPP000290;HMS1922G14;HMS2089L18;HMS2093I07;HMS2234N18;HMS3259L08;HMS3261A14;HMS3373A09;HMS3654H09;HMS3715F11;HMS3867I03;Pharmakon1600-01503678;ACT02648;BCP02156;EBD24636;KS-00000FW2;ZINC2570895;Tox21_111135;Tox21_201964;Tox21_300599;Tox21_500406;US8741944, Comparative Compound;4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;ABP000291;BBL029086;CCG-39354;NSC719627;NSC758624;s1261;STL373576;Celecoxib 1.0 mg/ml in Acetonitrile;4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide;AKOS015842517;Tox21_111135_1;AC-4228;AM84588;AT-3762;BCP9000507;CS-0570;DB00482;KS-1041;MCULE-4750749400;NC00708;NSC-719627;NSC-758624;SB19318;Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl);IDI1_000893;NCGC00091455-02;NCGC00091455-03;NCGC00091455-04;NCGC00091455-05;NCGC00091455-06;NCGC00091455-07;NCGC00091455-08;NCGC00091455-09;NCGC00091455-13;NCGC00254540-01;NCGC00259513-01;NCGC00261091-01;194044-54-7;AK-60967;BP-30217;HY-14398;LS-31667;NCI60_041049;PHA-00846533;SC-50829;SY064976;SBI-0051875.P002;AB0012055;CJ-016377;CP-598107;UNM-0000305813;FT-0601628;FT-0623536;FT-0700357;SW199611-3;PF-00345549;A25046;C-6317;C07589;D00567;J10035;AB00052396-07;AB00052396-08;AB00052396-09;AB00052396_10;AB00052396_11;590C425;Q408801;J-010566;J-520011;Q-200816;SR-01000837528-2;SR-01000837528-3;BRD-K02637541-001-02-4;BRD-K02637541-001-06-5;Z2210694606;Celecoxib, European Pharmacopoeia (EP) Reference Standard;Celecoxib, United States Pharmacopeia (USP) Reference Standard;4-[5-(p-Tolyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide;4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide;5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole;Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyazol-1-yl]benezenesulfonamide;Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-",Inhibitor of cyclooxygenase [COX] 2
6184667,https://pubchem.ncbi.nlm.nih.gov/compound/6184667,Ch 55,,Agonist of retinoid acid receptor (RAR)
161591,https://pubchem.ncbi.nlm.nih.gov/compound/161591,Chaetocin,,_
2700,https://pubchem.ncbi.nlm.nih.gov/compound/2700,Chaulmoogric Acid Ethyl Ester,,Agonist of the GPR40
2693,https://pubchem.ncbi.nlm.nih.gov/compound/2693,Chetomin,,Inhibitor of the hypoxia inducible factors
135399748,https://pubchem.ncbi.nlm.nih.gov/compound/135399748,CHIR124,,Inhibitor of the checkpoint kinase 1 (CHK1)
53396311,https://pubchem.ncbi.nlm.nih.gov/compound/53396311,CHIR98014,"CHIR-98014;252935-94-7;CHIR98014;CT-98014;CHEMBL3185148;6-N-[2-[[4-(2,4-dichlorophenyl)-5-imidazol-1-ylpyrimidin-2-yl]amino]ethyl]-3-nitropyridine-2,6-diamine;cc-83;GTPL8016;Chir98014, 20;SCHEMBL14672557;BDBM92356;AOB6865;DTXSID50694251;BCP01900;EX-A1079;BDBM50243389;s2745;ZINC42856088;AKOS015994559;BCP9000519;CCG-269591;CS-3122;ES-0004;SB19267;NCGC00346677-01;NCGC00346677-07;2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO-;AK547689;CT 98014;HY-13076;FT-0711479;Y0328;CHIR 98014, >=98% (HPLC);Q27075963;N*6*-{2-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine;N~6~-(2-{[4-(2,4-Dichlorophenyl)-5-(1H-imidazol-1-yl)pyrimidin-2-yl]amino}ethyl)-3-nitropyridine-2,6-diamine;N2-(2-((4-(2,4-dichlorophenyl)-5-(1H-imidazol-1-yl)pyrimidin-2-yl)amino)ethyl)-5-nitropyridine-2,6-diamine;n2-(2-(4-(2,4-dichlorophenyl)-5-(1h-imidazol-1-yl) pyrimidin-2-ylamino)ethyl)-5-nitropyridine-2,6-diamine;N2-(2-(4-(2,4-dichlorophenyl)-5-(1H-imidazol-1-yl)pyrimidin-2-ylamino)ethyl)-5-nitropyridine-2,6-diamine",Inhibitor of GSK-3 kinases
9956119,https://pubchem.ncbi.nlm.nih.gov/compound/9956119,CHIR99021,"CHIR-99021;252917-06-9;CHIR99021;CHIR 99021;CT99021;CT-99021;CT 99021;GSK-3 Inhibitor XVI;UNII-234CMT4GK4;CHIR-911;6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile;CHIR-99021 (CT99021);6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile;C22H18Cl2N8;234CMT4GK4;CHEMBL412142;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile;AK311166;6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile;3-Pyridinecarbonitrile, 6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl)amino)ethyl)amino)-;3-PYRIDINECARBONITRILE, 6-[[2-[[4-(2,4-DICHLOROPHENYL)-5-(5-METHYL-1H-IMIDAZOL-2-YL)-2-PYRIMIDINYL]AMINO]ETHYL]AMINO]-;CHIR 911;AQGNHMOJWBZFQQ-UHFFFAOYSA-N;6-[(2-([4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino)ethyl)amino]pyridine-3-carbonitrile;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile;65C;Kinome_3785;cc-59;SCHEMBL151139;BIFK0014;GTPL8014;TB4423-GMP;CHEBI:91091;CTK4F5391;KS-00000XOW;AOB3866;DTXSID90179931;EX-A535;QCR-164;SYN5163;ZX-AFC000324;BCPP000285;HMS3295O15;BCP01901;2318AH;ABP000490;BDBM50325983;s1263;ZINC29053046;AKOS015904410;AKOS026750421;AM81240;BCP9000520;CCG-269402;CS-0181;KIN0002408;SB19266;CHIR-99021,CT99021;NCGC00250379-01;NCGC00250379-03;NCGC00250379-09;NCGC00250379-21;6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile;AC-25532;AS-16523;HY-10182;SC-62210;CHIR99021, >=98% (HPLC);FT-0700271;A25048;S-7733;CHIR99021(CT99021)/CT-99021;J-015915;J-518185;BRD-K16189898-001-02-9;BRD-K16189898-001-04-5;BRD-K16189898-001-09-4;BRD-K16189898-001-10-2;BRD-K16189898-001-11-0;BRD-K16189898-001-15-1;Q27075965;6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidaz;[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile;3-Pyridinecarbonitrile,6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-;6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile;6-[(2-{[4-(2,4-dichlorophenyl) -5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol -2-yl)-pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)-pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino }ethyl)amino]pyridine-3-carbonitrile;6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3 -carbonitrile;6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5 -methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile;6-[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile;6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-2-imidazolyl)-2-pyrimidinyl]amino]ethylamino]-3-pyridinecarbonitrile;6-{2-[4-(2,4-dichloro-phenyl)-5-(4-methyl-1h-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile;6-{2-[4-(2,4-dichloro-phenyl)-5-(5-methyl-1h-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile;CHIR-99021|||6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile;CT99021;6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile",Inhibitor of GSK3β
2764,https://pubchem.ncbi.nlm.nih.gov/compound/2764,Ciprofloxacin,,_
129236,https://pubchem.ncbi.nlm.nih.gov/compound/129236,CKI 7,,Inhibitor of Wnt
5753,https://pubchem.ncbi.nlm.nih.gov/compound/5753,Compound B,,_
11306390,https://pubchem.ncbi.nlm.nih.gov/compound/11306390,Compound E,"Compound E;gamma-Secretase Inhibitor XXI;209986-17-4;(2S)-2-([(3,5-Difluorophenyl)acetyl]amino)-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide;(2S)-2-{[(3,5-Difluorophenyl)acetyl]amino}-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide;N2-[(3,5-difluorophenyl)acetyl]-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-L-alaninamide;SCHEMBL453584;CHEMBL1091498;DTXSID0042666;CTK8F8764;NOCAS_42666;C27H24F2N4O3;CHEBI:101713;CHEBI:131161;ZB1617;ZINC22309215;AKOS037435223;(S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanamide;(S,S)- 2-[2-(3,5-Difluorophenyl)-acetylamino]-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide;HY-14176;CS-0003250;J-013752;1,3-Dihydro-3beta-[[(S)-2-[(3,5-difluorophenyl)acetylamino]propionyl]amino]-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one;N(2)-[(3,5-difluorophenyl)acetyl]-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-L-alaninamide;N-[(1S)-2-[[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide",Inhibitor of the Notch signaling
442972,https://pubchem.ncbi.nlm.nih.gov/compound/442972,Cyclopamine,,Inhibitor of the Smoothened (SMO)
5458428,https://pubchem.ncbi.nlm.nih.gov/compound/5458428,Cytochalasin D,,_
24154,https://pubchem.ncbi.nlm.nih.gov/compound/24154,D-Galactosamine,,_
6419753,https://pubchem.ncbi.nlm.nih.gov/compound/6419753,D4476,,Inhibitor of the CK1
5311272,https://pubchem.ncbi.nlm.nih.gov/compound/5311272,DAPT,"dapt;208255-80-5;DAPT (GSI-IX);GSI-IX;gamma-Secretase Inhibitor IX;(S)-tert-butyl 2-((S)-2-(2-(3,5-difluorophenyl)acetamido)propanamido)-2-phenylacetate;CHEBI:86193;tert-butyl (2S)-2-[[(2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoyl]amino]-2-phenylacetate;N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine tert-butyl ester;N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester;GSIIX;PubChem22436;DAPT,GSI-IX;DAPT;;LY-374973;DAPT - GSI-IX;N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester;InSolution&trade; gamma-Secretase Inhibitor IX;MLS006010075;CHEMBL255682;QCR-29;SCHEMBL1360313;TB2634-GMP;KS-00000SRB;DTXSID00415519;EX-A324;C23H26F2N2O4;DWJXYEABWRJFSP-XOBRGWDASA-N;HMS3413L17;HMS3677L17;AOB33372;EBD16444;Glycine, N-[2-(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenyl-, 1,1-dimethylethyl ester, (2S)-;ZINC1549363;ABP000317;MFCD04974585;s2215;AKOS024457209;CCG-264944;CS-0264;SB19494;MRF-0000012;NCGC00167803-03;(3,5-Difluorophenylacetyl)-Ala-Phg-OtBu;AC-23163;AN-37124;AS-19399;HY-13027;SC-94298;SMR004701228;AB0033805;LS-191073;D4257;FT-0700262;SW219339-1;X7572;W-5319;AB01566837_01;J-013656;J-524356;Q27158972;(3,5-Difluorophenylacetyl)-L-alanyl-L-2-phenylglycine tert-Butyl Ester;N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine tert-butyl ester;N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester;(2S)-N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine 1,1-dimethylethyl ester;(2S)-N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenylglycine 1,1-dimethylethyl ester;N-[(3,5-Difluorophenyl)acetyl]-[l-alanyl-2-phenyl]glycine-1,1-dimethylethyl ester;N-[2-(3,5-Difluorophenyl)acetyl]-L-alanyl-L-(2-phenyl)glycine tert-butyl ester;N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine tert-butyl ester;;N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(2S)-2-phenylglycine tert-butyl ester;;N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester;;N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-(S)-phenylglycine tert-butyl ester;;N-[N-(3,5-difluorophenylacetyl)-L-alanyl]-L-phenylglycine tert-butyl ester;;N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}- (S)-phenylglycine tert-butyl ester;tert-butyl (2S)-({N-[(3,5-difluorophenyl)acetyl]-L-alanyl}amino)(phenyl)acetate;(S)-{(S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-propionylamino}-phenyl-acetic acid tert-butyl ester;t-butyl (2s)-2-[[(2s)-2-[[2-(3,5-difluorophenyl)acetyl]amino]propanoyl]amino]-2-phenylacetate;tert-butyl (2R)-[((2S)-2-{[(3,5-difluorophenyl)acetyl]aMino}propanoyl)aMino](phenyl)ethanoate",Inhibitor of γ-secretase
9934146,https://pubchem.ncbi.nlm.nih.gov/compound/9934146,db-cAMP,,CAMP agonist
5743,https://pubchem.ncbi.nlm.nih.gov/compound/5743,Dexamethasone,,Activator of glucocorticoid pathway
3033,https://pubchem.ncbi.nlm.nih.gov/compound/3033,Diclofenac,,Inhibitor of the Cyclooxygenase-2
512874,https://pubchem.ncbi.nlm.nih.gov/compound/512874,Dilauroyl phosphatidylcholine,,Agonist of the liver receptor homologue-1
50997747,https://pubchem.ncbi.nlm.nih.gov/compound/50997747,DMH1,"DMH-1;1206711-16-1;DMH1;4-[6-(4-propan-2-yloxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;DMH 1;CHEBI:86289;4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline;4-(6-{4-[(propan-2-yl)oxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)quinoline;CHEMBL2385597;SCHEMBL14671947;BDBM36354;AOB4088;DTXSID60679195;SYN5094;HMS3653K11;BCP09856;EX-A2049;s7146;ZINC62260292;DMH1, >=98% (HPLC);AKOS024457987;quinoline, 4-[6-[4-(1-methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-;CCG-268407;CS-3210;SB19483;NCGC00371039-08;AK547089;AS-16458;DA-34786;HY-12273;FT-0755960;SW220065-1;Y1886;J-004378;Q27159056;4-(6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin- 3-yl)quinoline;4-[6-[4-(1-Methylethoxy)phenyl]pyra zolo[1,5-a]pyrimidin-3-yl]-quinoline",Inhibitor of the BMP
11524144,https://pubchem.ncbi.nlm.nih.gov/compound/11524144,Dorsomorphin,"dorsomorphin;866405-64-3;6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine;Compound C;BML-275;AMPK Inhibitor, Compound C;6-[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine;CHEMBL478629;CHEBI:78510;4-(6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)pyridine;6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine;Dorsomorphin (Compound C);AMPK Inhibitor;BML-275 free base;Dorsomorphin(BML-275);InSolution&trade; AMPK Inhibitor, Compound C;UNII-10K52CIC1Z;SCHEMBL463155;10K52CIC1Z;BML275;GTPL4907;QCR-60;CTK5J7339;KS-00000QIT;AOB3605;Dorsomorphin, >=98% (HPLC);EX-A616;DTXSID401006988;HMS3229A20;HMS3673K07;BCP06649;ANW-67560;BDBM50262685;HY-13418A;MFCD08705402;s7840;ZINC13829435;AKOS005255631;ACN-048480;CCG-206817;CS-2487;DB08597;MCULE-1245787291;SB19028;6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine;NCGC00165869-01;NCGC00165869-02;NCGC00165869-03;NCGC00165869-23;AC-27419;AK-88052;AS-56360;AX8237195;B3252;D5394;FT-0700383;A11970;A841757;BRD-K54233340-300-01-0;Q27077101;C516138000;4-(6-{4-[2-(Piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-alpha]pyrimidin-3-yl)pyridine;6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine;6-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine;BML-275|||Compound C|||6-[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine","Inhibitor of ALK2, ALK3, ALK6, and AMPK"
73087,https://pubchem.ncbi.nlm.nih.gov/compound/73087,DZNep,"3-Deazaneplanocin;3-Deazaneplanocin A;102052-95-9;3-Deazaneplanocin,DZNep;(1s,2r,5r)-5-(4-amino-1h-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol;UNII-544SH4020S;CHEMBL154745;544SH4020S;3-Deaza-neplanocin;c^Neplanocin A;(1S,2R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol;3-Deazaneplanocin A (DZNep) hydrochloride;3-Cyclopentene-1,2-diol,5-(4-amino-1H-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)-, (1S,2R,5R)-;3-Deazaneplanocin-A;3-Deazaneplanocin A (DZNep;SCHEMBL863851;SCHEMBL12280736;CTK4A0628;DTXSID30144562;AVS-4275;3238AH;ABP000454;BDBM50096906;ZINC21290121;AKOS005146283;CS-0357;SB19350;AC-27393;HY-10442;SC-25094;W-5529;BRD-K77791657-001-01-1;Q15410156;3-Deazaneplanocin/DZNep/NSC617989/DZNepNSC617989;(-)-1-[(1R,4R,5S)-3-(Hydroxymethyl)-4,5-dihydroxy-2-cyclopenten-1-yl]4-aminoimidazo[4,5-c]pyridine;3-Cyclopentene-1,2-diol, 5-(4-amino-1H-imidazo(4,5-c)pyridiny-1-yl)-3-(hydroxymethyl)-, (1S-(alpha,2alpha,5beta))-;3-Cyclopentene-1,2-diol, 5-(4-amino-1H-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)-, (1S,2R,5R)-",Inhibitot of histone EZH2 lysine methyltransferase
1400,https://pubchem.ncbi.nlm.nih.gov/compound/1400,EI 275,,Inhibitor of Src-family kinase 
118987042,https://pubchem.ncbi.nlm.nih.gov/compound/118987042,Epiblastin A,,Inhibitor of the casein kinase 1 alpha
56962336,https://pubchem.ncbi.nlm.nih.gov/compound/56962336,EPZ004777,"EPZ004777;1338466-77-5;EPZ 004777;EPZ-004777;1-(3-((((2R,3S,4R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea;CHEMBL2169919;7-{5-[(3-{[(4-Tert-Butylphenyl)carbamoyl]amino}propyl)(Propan-2-Yl)amino]-5-Deoxy-Beta-D-Ribofuranosyl}-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine;WXRGFPHDRFQODR-ICLZECGLSA-N;0QK;1-[3-[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl-propan-2-ylamino]propyl]-3-(4-tert-butylphenyl)urea;GTPL7377;SCHEMBL9274416;DTXSID30719178;CHEBI:124920;C28H41N7O4;EX-A1764;2397AH;ABP001131;BDBM50396023;Daclatasvir (BMS790052 pound(c);s7353;ZINC89469833;AKOS022185751;CCG-269958;CS-2326;SB19224;NCGC00356803-12;AC-27388;HY-15227;SC-83236;FT-0771208;SW219207-1;Q27077205;3-[3-({[(2R,3S,4R,5R)-5-{4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl}(propan-2-yl)amino)propyl]-1-(4-tert-butylphenyl)urea;7-[5-Deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-?-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7-[5-Deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",Inhibitor of H3K79 histone methyltransferase DOT1L
36462,https://pubchem.ncbi.nlm.nih.gov/compound/36462,Etoposide,,_
47936,https://pubchem.ncbi.nlm.nih.gov/compound/47936,Forskolin,"forskolin;Colforsin;66575-29-9;Coleonol;colforsina;colforsine;colforsinum;Boforsin;Colforsine [French];Colforsinum [Latin];Colforsina [Spanish];Coleonolk;Colforsin [USAN:INN];UNII-1F7A44V6OU;7beta-Acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one;EINECS 266-410-9;HL 362;(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-5-yl acetate;NSC 357088;NSC 375489;CHEMBL52606;1F7A44V6OU;L 75 1362B;CHEBI:42471;C22H34O7;HL-362;NSC375489;NCGC00024996-02;L-751362B;7-beta-Acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-one;DSSTox_CID_20484;DSSTox_RID_79500;DSSTox_GSID_40484;Forsklin;(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]chromen-5-yl acetate;(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-Dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1H-naphtho(2,1-b)pyran-1-one 5-acetate;ForsLean;1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3R-(3alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha))-;1H-Naphtho(2,1-b)pyran-1-one, dodecahydro-5-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-6,10,10b-trihydroxy-, (3R-(3-alpha,4a-beta,5-beta,6-beta,6a-alpha,10-alpha,10a-beta,10b-alpha))-;1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-;FOK;SMR000471881;CAS-66575-29-9;Forskolin, Coleus forskohlii;Ocufors;Timsaponin-C;66428-89-5;Colforsin (USAN/INN);forskolin/ rolipram mixture;MolMap_000021;SCHEMBL4928;cid_47936;MLS001066384;MLS001333255;MLS001333256;MLS002172462;MLS002695942;Forskolin, analytical standard;Forskohlii Root Extract (ForsLean)(20% forskohlin);REGID_for_CID_47936;GTPL5190;DTXSID8040484;BCBcMAP01_000132;OHCQJHSOBUTRHG-KGGHGJDLSA-;AOB6380;BIF1031;OHCQJHSOBUTRHG-KGGHGJDLSA-N;ZX-AFC000211;Bio1_000443;Bio1_000932;Bio1_001421;HMS2235C17;HMS3267I16;HMS3412G19;HMS3676G19;ZINC3977779;Tox21_110940;Tox21_302399;BDBM50010261;MFCD00082317;s2449;7beta-Acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxy-labd-14-en-11-one;AKOS024456384;Tox21_110940_1;ACN-035218;AM81249;CCG-268774;CS-1454;DB02587;LMPR0104030004;PXT0000105;SMP1_000128;NCGC00024996-03;NCGC00024996-04;NCGC00024996-05;NCGC00024996-06;NCGC00177971-03;NCGC00255526-01;1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-;5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho(2,1-b)pyran-1-one;AS-17443;CC-28833;HY-15371;LS-95557;SC-47275;F0855;FT-0626543;M-410;V0151;Y0448;7088-EP2280000A1;7088-EP2284169A1;7088-EP2287147A2;7088-EP2287161A1;7088-EP2287162A1;7088-EP2287165A2;7088-EP2287166A2;7088-EP2292620A2;7088-EP2295550A2;7088-EP2301931A1;7088-EP2301937A1;7088-EP2308562A2;7088-EP2311806A2;7088-EP2371811A2;C09076;D03584;MLS-0318096.0001;S-7769;C-21901;Q412747;SR-01000597378;Forskolin, For use in molecular biology applications;Q-200888;SR-01000597378-1;BRD-K09602097-001-04-5;Forskolin, from Coleus forskohlii, >=98% (HPLC), powder;Forskolin, United States Pharmacopeia (USP) Reference Standard;(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1H-naphtho[2,1-b]pyran-5-yl acetate;[(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyl-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetate;[3R-(3<alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha)]-5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one;[3R-(3?,4a?,5?,6?,6a?,10?,10a?,10b?)]-5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one;[3R-(3a,4ab,5b,6b,6aa,10a,10ab,10ba)]-5-(Acetyloxy)-3-e thenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one;InChI=1/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21,22-/m0/s1",CAMP agonist
11493598,https://pubchem.ncbi.nlm.nih.gov/compound/11493598,FR180204,,Inhibitor of the ERK
24776445,https://pubchem.ncbi.nlm.nih.gov/compound/24776445,GDC-0449,"Vismodegib;879085-55-9;GDC-0449;Erivedge;2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide;Vismodegib (GDC-0449);HhAntag691;GDC0449;GDC 0449;GDC-0449 (Vismodegib);UNII-25X868M3DS;NSC-747691;CHEMBL473417;CHEBI:66903;25X868M3DS;NSC755986;AK-77261;2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide;2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide;2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide;C19H14Cl2N2O3S;2-chloro-n-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)benzamide;2-chloro-N-(4-chloro-3-pyridin-2-yl-phenyl)-4-methanesulfonyl-benzamide;2-Chloranyl-~{n}-(4-Chloranyl-3-Pyridin-2-Yl-Phenyl)-4-Methylsulfonyl-Benzamide;Erivedge (TN);Vismodegib [USAN:INN];NSC 747691;vismodegibum;HSDB 8130;R 3616;NSC747691;Hh-Antag691;HhAntag 691;Vismodegib, free base;RG-3616;methanesulfonylbenzamide;PubChem19137;Vismodegib (USAN/INN);Vismodegib; GDC-0449;R-3616;GDC-0449 - Selumetinib;cc-580;MLS006012035;SCHEMBL302587;GTPL6975;QCR-40;CTK8B8648;AOB1040;CUR-691;DTXSID40236689;GDC-449;BPQMGSKTAYIVFO-UHFFFAOYSA-N;BCPP000223;HMS3604K16;HMS3654E17;BCP01715;EX-A2178;KS-000000BH;ABP000894;ANW-60962;BDBM50249522;BG0661;s1082;ZINC40899447;GDC-0449(Vismodegib)/GDC0449;GDC-0449,Vismodegib, HhAntag691;AKOS015966534;BCP9000713;CCG-264811;CS-0255;DB08828;MCULE-6680076172;NSC-755986;PB15086;NCGC00242497-01;NCGC00242497-02;NCGC00242497-06;4CA-1325;AC-26969;AS-14066;HY-10440;SC-87729;SMR004703564;AB0008125;AX8167197;FT-0675833;SW218087-2;X4669;EC-000.2333;A10258;D09992;J90022;Q-2305;V-4050;AB01565813_02;085G559;SR-01000941574;2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-;J-509076;Q2070286;SR-01000941574-1;C538724000;2-Chloro-N-(4-chloro-3-(2-pyridl)phenyl)-4-(methylsulfonyl)benzamide;2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methyl sulfonyl)benzamide;2-Chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methanesulfonyl)benzamide;2-chloro-N~1~-[4-chloro-3-(2-pyridyl)phenyl]-4-(methylsulfonyl)benzamide;2-CHLORO-N-[4-CHLORO-3-(2-PYRIDINYL)PHENYL]-4-(METHYLSULFONYL)-BENZAMIDE;Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-;GD 0449|||2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide;VIS",Inhibitor of the sonic hedgehog
5288382,https://pubchem.ncbi.nlm.nih.gov/compound/5288382,Geldanamycin,,Inhibitor of the Heat Shock Protein 90
3499,https://pubchem.ncbi.nlm.nih.gov/compound/3499,GO6983,"go 6983;133053-19-7;Go6983;Goe 6983;Go-6983;Go-6893;3-[1-[3-(Dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione;Goe-6983;G? 6983;G&ouml; 6983;3-(1-(3-(dimethylamino)propyl)-5-methoxy-1H-indol-3-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione;3-{1-[3-(dimethylamino)propyl]-5-methoxy-1H-indol-3-yl}-4-(1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione;LLJJDLHGZUOMQP-UHFFFAOYSA-N;2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1h-indol-3-yl)maleimide;Gouml 6983;MLS006011225;BIFK0056;CHEMBL261491;GTPL5192;SCHEMBL1680253;CHEBI:91455;CTK4B8320;DTXSID60274402;HMS3229E15;HMS3650B11;HMS3651D10;BCP06669;EX-A1221;ZINC2526562;2438AH;MFCD04040031;s2911;AKOS024457028;CCG-206756;CS-2433;SB19440;2-[1-(3-Dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide;3-[1-[3-(dimethylamino)propyl]-5-methoxyindol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione;KS-000000Z7;NCGC00163505-01;NCGC00163505-03;AK232528;AS-74619;Go6983(96%);HY-13689;SMR004702986;SW219419-1;SR-01000946321;J-006294;SR-01000946321-1;Q27077833;G?? 6983, >=97%;1H-Pyrrole-2,5-dione, 3-[1-[3-(dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-;Goe 6983|||3-[1-[3-(Dimethylamino)propyl]-5-methoxyindol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione",Inhibitor of protein kinase C
68210102,https://pubchem.ncbi.nlm.nih.gov/compound/68210102,GSK126,"GSK126;1346574-57-9;GSK-126;EZH2 inhibitor;GSK 126;UNII-W4OGW9QZ97;GSK-2816126;W4OGW9QZ97;CHEMBL3287735;(S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide;1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indole-4-carboxamide;FKSFKBQGSFSOSM-QFIPXVFZSA-N;A9G;N-((1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-1H-indole-4-carboxamide;N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide;MLS006010251;GTPL7012;SCHEMBL12180401;AOB1764;EX-A499;SYN5012;CHEBI:124921;BCP06129;KS-00000XH6;BDBM50017293;GSK-2816126A;s7061;ZINC72318146;AKOS027322309;CCG-269895;CS-1401;GSK2816126;QC-9703;NCGC00347286-01;AS-16379;HY-13470;SC-94427;SMR004701327;AB0032512;FT-0700443;X5824;W-6022;Q27077865;EZH2 inhibitor;GSK-126;GSK 126;GSK2816126A;GSK-2816126A;GSK 2816126A;(S)-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide;1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide;1H-Indole-4-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-;N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide",Inhibitor of the EZH2 methyltransferase
107864,https://pubchem.ncbi.nlm.nih.gov/compound/107864,HC-Toxin,,Inhibitor of the HDAC
44195701,https://pubchem.ncbi.nlm.nih.gov/compound/44195701,Hh-Ag1.5,,Agonist of the Smoothened (Smo) receptor; activator of the sonic hedgehog (Shh) signaling
52912189,https://pubchem.ncbi.nlm.nih.gov/compound/52912189,I-BET151,"1300031-49-5;I-BET151;GSK1210151A;I-BET151 (GSK1210151A);7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one;7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]quinolin-2-one;CHEMBL2017291;I-BET 151;(R)-7-(3,5-dimethylisoxazol-4-yl)-8-methoxy-1-(1-(pyridin-2-yl)ethyl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one;I-BET-151;7-(3,5-Dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-(pyridin-2-yl)ethyl]-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one;7-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-8-Methoxy-1-[(1r)-1-(Pyridin-2-Yl)ethyl]-1h,2h,3h-Imidazo[4,5-C]quinolin-2-One;3zyu;4alg;VUVUVNZRUGEAHB-CYBMUJFWSA-N;1GH;cc-415;MLS006011182;GTPL7518;IBET-151;SCHEMBL1906755;CHEBI:95083;KS-00000PYL;DTXSID10680599;QCR-236;7-(3,5-dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-pyridin-2-ylethyl]-3H-imidazo[4,5-c]quinolin-2-one;BCP03612;EX-A1561;BDBM50380682;GSK 1210151A;GSK-1210151A;s2780;ZINC73069302;AKOS016004407;BCP9000734;CS-0930;SB19333;GSK1210151A/I-BET 151;NCGC00344588-01;NCGC00344588-08;7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]q;AC-27406;HY-13235;SMR004702951;BCP0726000180;AB0032511;SW219264-1;X5823;A11783;F10218;W-5867;J-519026;Q27078015;2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-;7-(3,5-Dimethyl-4-isoxazolyl)-8-(methyloxy)-1-[(1R)-1-(2-pyridinyl)ethyl]-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one;7-(dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-(pyridin-2-yl)ethyl]-1H,2H,3H-imidazo[4,5-c]quinolin-2-one",Inhibitor of the BET family
3758,https://pubchem.ncbi.nlm.nih.gov/compound/3758,IBMX,"IBMX;3-Isobutyl-1-methylxanthine;28822-58-4;isobutylmethylxanthine;1-METHYL-3-ISOBUTYLXANTHINE;Methylisobutylxanthine;3-Isobutyl-1-methyl-1H-purine-2,6(3H,7H)-dione;3-isobutyl-1-methylxanthine (ibmx);1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-;Xanthine, 3-isobutyl-1-methyl-;3-Isobutyl-1-methyxanthine;Methyl-isobutylxanthine;3-isobutyl-1-methyl-7H-xanthine;1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione;3-Isobutyl 1-methylxanthine;UNII-TBT296U68M;NSC 165960;CCRIS 4290;CHEBI:34795;C10H14N4O2;3,7-Dihydro-3-isobutyl-1-methyl-1H-purine-2,6-dione;3-Isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione;3-isobutyl-1-methyl-3,9-dihydro-1H-purine-2,6-dione;2-Acetoxy-Benzoic Acid;3-Isobutyl-Methylxanthine;EINECS 249-259-3;NSC165960;1-methyl-3-(2-methylpropyl)-3,7-dihydro-1H-purine-2,6-dione;CHEMBL275084;TBT296U68M;APIXJSLKIYYUKG-UHFFFAOYSA-N;1-methyl-3-(2-methylpropyl)-3,9-dihydro-1H-purine-2,6-dione;3,7-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione;J-640140;1-methyl-3-(2-methylpropyl)-1,3,7-trihydropurine-2,6-dione;1H-purine-2,6-dione, 3,9-dihydro-1-methyl-3-(2-methylpropyl)-;3-Isobutyl-1-methylxanthine, 99%;Isobutyltheophylline;IMX;SMR000326697;SR-01000075185;1zkl;1zkn;3ecn;3itu;3jwr;MFCD00005584;2hd1;2r8q;3qi4;Spectrum2_001705;Spectrum2_001735;Spectrum3_001958;Spectrum4_001052;Spectrum5_001856;Lopac-I-5879;MolMap_000030;Lopac0_000642;Oprea1_135287;Oprea1_228781;SCHEMBL50315;3-isobutyl-1-methylxantliine;BSPBio_001153;BSPBio_003558;GTPL388;KBioGR_000493;KBioGR_001344;KBioGR_002566;KBioSS_000493;KBioSS_002575;1-methyl-3-isobutyl-xanthine;MLS001056732;MLS001066424;3-Isobutyl-1-methyl-xanthine;DivK1c_000922;SPECTRUM1505298;SPECTRUM2300204;SPBio_001690;SPBio_001810;DTXSID0040549;BCBcMAP01_000110;BDBM15336;CHEBI:43253;CTK3J1633;HMS502O04;KBio1_000922;KBio2_000493;KBio2_002566;KBio2_003061;KBio2_005134;KBio2_005629;KBio2_007702;KBio3_000905;KBio3_000906;KBio3_002878;KBio3_003044;KS-00001CXM;3-isobutyl-1-methyl-9H-xanthine;cMAP_000087;NINDS_000922;Bio1_000456;Bio1_000945;Bio1_001434;Bio2_000407;Bio2_000887;HMS1362I15;HMS1792I15;HMS1990I15;HMS2090J10;HMS2231C11;HMS3262A05;HMS3369E16;HMS3403I15;HMS3604D14;HMS3648O18;ALBB-024315;BCP13248;ZINC3861807;Tox21_500642;3-ISOBUTHYL-1-METHYLXANTHINE;ANW-54495;BDBM50027176;BS0316;CCG-39513;CCG-39624;GL2425;HSCI1_000261;PDSP1_000324;PDSP2_000322;s5836;SC2964;STL558248;AKOS003390599;AKOS015903085;CS-3361;DB07954;LP00642;MCULE-3854999514;NSC-165960;SC 2964;SDCCGSBI-0050622.P003;VZ21530;IDI1_000922;IDI1_002162;NCGC00015559-01;NCGC00015559-02;NCGC00015559-03;NCGC00015559-04;NCGC00015559-05;NCGC00015559-06;NCGC00015559-07;NCGC00015559-08;NCGC00015559-09;NCGC00015559-10;NCGC00015559-11;NCGC00094009-01;NCGC00094009-02;NCGC00094009-03;NCGC00094009-04;NCGC00094009-05;NCGC00094009-06;NCGC00261327-01;Xanthine, 1-methyl-3-(2-methylpropyl);AK-84450;AS-71134;HY-12318;SC-84962;ST055758;IBMX(NSC165960; SC2964);3-isobutyl-1-methyl-7H-purine-2,6-dione;AX8087568;DB-047466;LS-162537;[Eur J Pharmacol 170: 35 (1989)];B7206;EU-0100642;FT-0615920;R4973;WLN: T56 BM DN FNVNVJ F1Y1&1 H1;3-Isobutyl-1-methyl-2,6(1H,3H)-purinedione;C13708;I 5879;3-Isobutyl-1-methylxanthine, BioUltra, >=99%;822I584;L001156;Q223093;J-800144;SR-01000075185-1;SR-01000075185-6;3-Isobutyl-1-methylxanthine, >=99% (HPLC), powder;BRD-K94979336-001-06-9;BRD-K94979336-001-09-3;1H-Purine-2, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-;IMX;Isobutylmethylxanthine;Methylisobutylxanthine;NSC165960;SC2964;1-methyl-3-(2-methylpropyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione;1-methyl-3-(2-methylpropyl)-2,3,6,9-tetrahydro-1H-purine-2,6-dione",Inhibitor of the cyclic nucleotide phosphodiesterases
11238147,https://pubchem.ncbi.nlm.nih.gov/compound/11238147,ICG-001,,Inhibitor of Wnt
23749403,https://pubchem.ncbi.nlm.nih.gov/compound/23749403,IDE1,,Activator of the activin/BMP/TGF-β pathway
19582717,https://pubchem.ncbi.nlm.nih.gov/compound/19582717,ISX9,"832115-62-5;ISX-9;isx 9;Isoxazole 9;N-Cyclopropyl-5-(thiophen-2-yl)isoxazole-3-carboxamide;Isoxazole 9 (ISX-9);N-cyclopropyl-5-thiophen-2-yl-1,2-oxazole-3-carboxamide;N-cyclopropyl-5-thiophen-2-yl-3-isoxazolecarboxamide;C11H10N2O2S;N-cyclopropyl-5-(thiophen-2-yl)-1,2-oxazole-3-carboxamide;ISX;Isx9;Neuronal Differentiation Inducer III;Isoxazole 9(ISX9);SCHEMBL509365;CHEMBL1222381;CHEBI:95020;CTK8G1808;AOB1051;DTXSID50880071;EX-A937;SYENTKHGMVKGAQ-UHFFFAOYSA-N;BCP16038;ZINC2803051;s7914;AKOS004090583;CCG-266818;CS-5072;MCULE-5086978565;NE59641;NCGC00182348-01;AK473826;AS-16612;HY-12323;B5596;FT-0699834;J3.551.730H;N-Cyclopropyl-5-(2-thienyl)-3-isoxazolecarboxamide;N-Cyclopropyl-5-(2-thienyl)isoxazole-3-carboxamide;BRD-K53903639-001-01-3;N-Cyclopropyl-5-(2-thienyl)-3-isoxa zolecarboxamide;Q27166781;N-cyclopropyl-5-(thiophen-2-yl)-isoxazole-3-carboxamide",Neurogenic Modulator
_,_,IWP-2,_,Inhibitor of Wnt
2155264,https://pubchem.ncbi.nlm.nih.gov/compound/2155264,IWP-4,"IWP-4;686772-17-8;IWP 4;2-((3-(2-methoxyphenyl)-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(6-methylbenzo[d]thiazol-2-yl)acetamide;CHEMBL1257090;N-(6-Methylbenzo[d]thiazol-2-yl)-2-(3-(2-methoxyphenyl)-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-ylthio)acetamide;wnt inhibitor iwp-4;SCHEMBL12571760;C26H29ClN2O4S.H3PO4;EX-A2455;ZINC2719825;BDBM50428027;AKOS024584894;MCULE-3532196300;IWP-4, >=95% (HPLC);NCGC00387247-04;AS-35152;HY-12879;CS-0012738;EU-0088918;AB00668741-01;F0579-0237;N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-3-(2-methoxyphenyl)-4-oxothieno[3,2-d]pyrimidin-2-yl)thio]-acetamide;N-[2-[[[3-(4-Chlorophenyl)-2-propen yl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4 -methoxybenzenesulphonamide phosphate",Inhibitor of the WNT pathway
3137736,https://pubchem.ncbi.nlm.nih.gov/compound/3137736,IWR1,IWR-1-endo;IWR-1;1127442-82-3;IWR1-endo;ChemDiv1_005302;Oprea1_037138;Oprea1_443063;SCHEMBL12549749;CTK8F0329;HMS602A22;AKOS026750583;MCULE-3071241001;AS-56164;DA-34780;EU-0039994;FT-0670579;SR-01000448491;SR-01000448491-1,Inhibitor of WNT pathway
5494425,https://pubchem.ncbi.nlm.nih.gov/compound/5494425,JAK inhibitor I,"Pyridone 6;457081-03-7;JAK Inhibitor I;Merck-5;CMP 6;Merck 5;CMP-6;2-tert-butyl-9-fluoro-3H-benzo[h]imidazo[4,5-f]isoquinolin-7(6H)-one;CHEMBL21156;2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one;2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE;CHEBI:87103;Compound # 2;2-TERT-BUTYL-9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLINE-7-ONE;C18H16FN3O;2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one;2-tert-butyl-9-fluoro-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;4-tert-butyl-15-fluoro-3,5,10-triazatetracyclo[11.4.0.0,.0,]heptadeca-1(13),2(6),4,7(12),8,14,16-heptaen-11-one;P6;JAK I inhibitor;InSolution&trade; JAK Inhibitor I;PDK1 inhibitor, 1;Kinome_3740;PubChem22471;2b7a;Merck-5;CMP 6;CMP 6; Pyridone 6;LDX3F0CCST;UNII-LDX3F0CCST;Tetracyclic Pyridone, 1;SCHEMBL904545;GTPL5992;STO185;BDBM26198;CTK8E9239;DTXSID40420526;EX-A123;SYN1054;VNDWQCSOSCCWIP-UHFFFAOYSA-N;BCPP000167;HMS3229G07;HMS3244K21;HMS3244K22;HMS3244L21;BCP01959;3809AH;ZINC12504479;AKOS026750650;AKOS030240416;AKOS032949970;BCP9000906;CCG-206761;CS-1056;DB04716;SB18936;NCGC00345828-01;NCGC00345828-07;4CA-0807;AM806646;AS-16211;HY-14435;QC-10171;AB0007901;FT-0700310;Y0239;K00013;K00225;W-5672;SR-03000000978-1;Q27096425;2-(tert-butyl)-9-fluoro-3H-benzo[h]imidazo[4,5-f]isoquinolin-7(6H)-one;2-(1,1-Dimethylethyl)-9-fluoro-1,6-dihydro-7H-benz[h]imidazo[4,5-f]isoquinolin-7-one;2-(1,1-dimethylethyl)-9-fluoro-3,6-dihydro-7h-benz [h]-imidazo [4,5-f]isoquinolin-7-one;2-tert-butyl-9-fluoro-1,6-dihydro-7h-benzo[h]imidazo[4,5-f]isoquinolin-7-one;4-TERT-BUTYL-15-FLUORO-3,5,10-TRIAZATETRACYCLO[11.4.0.0(2),?.0?,(1)(2)]HEPTADECA-1(13),2(6),4,7(12),8,14,16-HEPTAEN-11-ONE;4-tert-butyl-15-fluoro-3,5,10-triazatetracyclo[11.4.0.0^{2,6.0^{7,12]heptadeca-1(13),2(6),4,7(12),8,14,16-heptaen-11-one;4-tert-butyl-15-fluoro-3,5,10-triazatetracyclo[11.4.0.0^{2,6}.0^{7,12}]heptadeca-1(13),2(6),3,7(12),8,14,16-heptaen-11-one;4-tert-butyl-15-fluoro-3,5,10-triazatetracyclo[11.4.0.0^{2,6}.0^{7,12}]heptadeca-1(17),2(6),4,7(12),8,13,15-heptaen-11-one;JAK Inhibitor I; 2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one",JAK inhibitor
9797370,https://pubchem.ncbi.nlm.nih.gov/compound/9797370,JNJ10198409,"JNJ-10198409;627518-40-5;PDGF Receptor Tyrosine Kinase Inhibitor IV;N-(3-fluorophenyl)-6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-amine;CHEMBL120077;3-Fluoro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine;JNJ-?10198409;PDGFR Tyrosine Kinase Inhibitor IV;ZDNURMVOKAERHZ-UHFFFAOYSA-N;GTPL6020;SCHEMBL3088170;CTK8E8807;jnj10198409;DTXSID70430890;HMS3229I11;HMS3650O03;HMS3674K21;BCP08276;BDBM50179207;ZINC13677843;CCG-206773;CS-W011982;HY-W011266;NCGC00343986-02;JNJ 10198409;JNJ-10198409, >=98% (HPLC), solid;SR-01000946814;SR-01000946814-1;Q27088285;N-(3-Fluorophenyl)-1,4-dihydro-6,7-dimethoxyindeno[1,2-c]pyrazol-3-amine;N-(3-fluorophenyl)-2,4-dihydro-6,7-dimethoxyindeno[1,2-c]pyrazol-3-amine;N-(3-fluorophenyl)-6,7-dimethoxy-1H,4H-indeno[1,2-c]pyrazol-3-amine;(3-Fluoro-phenyl)-(6,7-dimethoxy-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-amine;(6,7-Dimethoxy-1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-(3-fluoro-phenyl)-amine;JNJ 10198409;JNJ10198409; RWJ-540973; RWJ 540973; RWJ540973",_
16760383,https://pubchem.ncbi.nlm.nih.gov/compound/16760383,KAAD Cyclopamine,,Inhibitor of Smoothened (Smo) and Sonic hedgehog
16047442,https://pubchem.ncbi.nlm.nih.gov/compound/16047442,KC7f2,,Inhibitor of HIF 1-alpha
3820,https://pubchem.ncbi.nlm.nih.gov/compound/3820,Kenpaullone,,Inhibitor of the GSK3β
10990876,https://pubchem.ncbi.nlm.nih.gov/compound/10990876,L-Ascorbic acid 2-phosphate trisodium salt,,_
24775005,https://pubchem.ncbi.nlm.nih.gov/compound/24775005,LDE225,"Erismodegib;Sonidegib;956697-53-3;LDE225;NVP-LDE225;Odomzo;LDE-225;NVP-LDE 225;LDE 225;UNII-0RLU3VTK5M;LDE225 (NVP-LDE225,Erismodegib);0RLU3VTK5M;LDE225 (NVP-LDE225; Erismodegib);N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide;Odomozo;N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide;Sonidegib [USAN:INN];Erismodegib [USAN:INN];LDE225(NVP-LDE225);PubChem22446;Sonidegib (USAN/INN);erismodegib (deleted INN);cc-76;NVP-LDE225(Erismodegib);MLS006011198;NVP-LDE-225;SCHEMBL554455;GTPL8199;CHEMBL2105737;NVP-LDE225/LDE225;CHEBI:90863;EX-A409;C26H26F3N3O3;VZZJRYRQSPEMTK-CALCHBBNSA-N;DTXSID501009335;BCP02275;KS-00000TD3;LDE 225, NVP-LDE225;LDE225 - NVP-LDE225;ABP000896;BDBM50394562;HY-16582A;s2151;ZINC68202099;AKOS015994541;BCP9001014;CCG-264935;CS-0904;DB09143;EE-0005;SB16676;LDE225 (NVP-LDE225, Erismodegib);NCGC00250382-01;NCGC00250382-05;(1,1'-Biphenyl)-3-carboxamide, N-(6-((2R,6S)-2,6-dimethyl-4-morpholinyl)-3-pyridinyl)-2- methyl-4'-(trifluoromethoxy)-, rel-;[1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(t;[1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-, rel-;4CA-0728;HY-10296;N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide;SC-85832;SMR004702967;FT-0667957;SW218115-2;X7564;D10119;W-5625;BRD-K19796430-001-01-5;Q22075856;Erismodegib|||LDE 225|||NVP-LDE 225|||N-[6-[(2S,6R)-2,6-Dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;N-(6-((2R,6S)-2,6-Dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'- (trifluoromethoxy)biphenyl-3-carboxamide;n-(6-((2r,6s)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide;N-(6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl)-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-3-pyridyl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide;rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide;rel-N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide",_
25195294,https://pubchem.ncbi.nlm.nih.gov/compound/25195294,LDN193189,"1062368-24-4;LDN193189;LDN-193189;UNII-W69H5YQU9O;4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline;LDN 193189;W69H5YQU9O;CHEMBL513147;4-[6-(4-Piperazin-1-Ylphenyl)pyrazolo[1,5-A]pyrimidin-3-Yl]quinoline;4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;4-{6-[4-(piperazin-1-yl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl}quinoline;LDN 193189 hydrochloride;DM 3189 hydrochloride;LDN193189 free base;cc-233;SCHEMBL456393;CHEBI:91387;KS-00000SOA;AOB3009;DTXSID30147553;EX-A424;HMS3743E21;BCP01907;ABP000266;BDBM50262079;s2618;ZINC40880920;AKOS024464854;Quinoline, 4-(6-(4-(1-piperazinyl)phenyl)pyrazolo(1,5-a)pyrimidin-3-yl)-;BCP9000845;CS-0669;EX-8677;SB19315;NCGC00249389-01;4CA-0730;AK163404;AS-73735;HY-12071;QC-11402;SC-67268;AB0033774;FT-0753749;X7510;A25220;W-5677;cas:1062368-24-4;LDN193189;J-514252;LDN193189(DM3189)/LDN-193189;BRD-K04853698-003-01-4;Q27163247;4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyri;LDN 193189; LDN-193189; DM-3189; DM 3189;4-[6-(4-Piperazin-1-yl-phenyl)-pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline hydrochloride;DM3189;6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine",Inhibitor of TGF-beta/Smad signaling
53232,https://pubchem.ncbi.nlm.nih.gov/compound/53232,Lovastatin,,_
447966,https://pubchem.ncbi.nlm.nih.gov/compound/447966,LY-364947,"396129-53-6;LY-364947;LY364947;4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline;4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE;TGF-beta RI Kinase Inhibitor;HTS 466284;TbetaR-I Inhibitor;LY 364947;HTS-466284;4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline;CHEMBL261454;4-[5-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline;Quinoline, 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-;AK-35014;Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor;4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline;4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline;4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline;ALK5 Inhibitor I;SR-01000385325;4-(5-pyridin-2-yl-1H-pyrazol-4-yl)quinoline;1py5;Peakdale1_000394;[3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole;cc-654;SCHEMBL373665;GTPL6050;SCHEMBL21233972;BDBM21492;CHEBI:91198;CHEBI:92118;CTK1B3814;HMS519B20;AOB6754;DTXSID90332266;EX-A133;HMS2043N21;HMS3229M09;HMS3269P09;HMS3648O10;HMS3677D10;HMS3742E17;BCP05350;KS-00001D6O;ZX-AT000925;MFCD00800758;OR7811;s2805;ZINC15894680;AKOS015854224;AKOS025394671;AKOS026750326;BCP9000886;CCG-206795;CS-3451;DB03921;PS-7269;SB19489;NCGC00167839-01;NCGC00167839-15;4CA-0791;AC-30262;HY-13462;PY1;AX8136899;FT-0676988;X5937;EC-000.2417;4-(3-pyridin-2-yl)-1h-pyrazol-4-ylquinoline;A13446;Z-3279;LY-364947, >=98% (HPLC);[3-(pyridin-2-yl)-4-(4-quinolinyl)]-1h-pyrazole;4-[(3-Pyridin-2-yl)-1H-pyrazol-4-yl)]quinoline;J-513403;SR-01000385325-1;SR-01000385325-2;4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]??-quinoline;BRD-K06234293-001-01-8;Q27088977",TGF-b signalling inhibitor
3973,https://pubchem.ncbi.nlm.nih.gov/compound/3973,Ly294002,,Inhibitor of the PI3 kinase
5497152,https://pubchem.ncbi.nlm.nih.gov/compound/5497152,Lysophosphatidic acid,,Phospolipid derivative
129010138,https://pubchem.ncbi.nlm.nih.gov/compound/129010138,MM-589,,Inhibitor Mll1
12035,https://pubchem.ncbi.nlm.nih.gov/compound/12035,N-Acetyl-L-cysteine,,_
448222,https://pubchem.ncbi.nlm.nih.gov/compound/448222,NECA,"NECA;5'-N-Ethylcarboxamidoadenosine;35920-39-9;Adenosine-5'-(N-ethylcarboxamide);[3H]NECA;N-ethyl-5'-carboxamidoadenosine;1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D-ribofuranuronamide;MLS000069759;CHEMBL464859;CHEBI:73284;5'-N-ETHYLCARBOXAMIDO-ADENOSINE;SMR000058759;N-Ethylcarboxamidoadenosine;N-ETHYL-5'-CARBOXAMIDO ADENOSINE;5'-N(Sup 6)-Ethylcarboxamidoadenosine;(2S,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide;(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide;NEC;5'-ethylcarboxamidoadenosine;Adenosine, N6-Ethyl-carboxamido;2ydv;Adenosine analog, 3;[3H]adenosine-5'-(N-ethylcarboxamide);1qy5;Opera_ID_470;GTPL377;GTPL425;5'-Ethylcarboxamido-adenosine;MLS002153347;5'-Ethylcarboxamido Adenosine;beta-D-Ribofuranuronamide, 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-;REGID_for_CID_448222;SCHEMBL16585523;BDBM21220;Adenosine-5-(N-ethylcarboxamide);JADDQZYHOWSFJD-FLNNQWSLSA-N;HMS2234O07;HMS3412B16;HMS3676B16;ZINC3995401;MFCD00069195;AKOS024456749;CS-8131;NCGC00025260-02;NCGC00025260-03;NCGC00025260-04;NCGC00025260-05;5'-(N-Ethylcarboxamido)adenosine, powder;AC-27392;SC-97607;HY-103173;Q27087892;5 inverted exclamation mark -Ethylcarboxamido Adenosine;1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-?-D-ribofuranuronamide;(2S,3S,4R)-5-(6-Aminopurin-9-yl)-N-ethyl-3,4-dihydroxy-oxolane-2-carboxamide;(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide;5''-N-Ethylcarboxamidoadenosine; D-NECA; NECAMolecular Formula: C12H16N6O4;(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name)",Agonist of the cAMP
936,https://pubchem.ncbi.nlm.nih.gov/compound/936,Nicotinamide,,_
89594,https://pubchem.ncbi.nlm.nih.gov/compound/89594,Nicotine,,_
789882,https://pubchem.ncbi.nlm.nih.gov/compound/789882,OAC1,"OAC1;300586-90-7;OAC-1;BAS 00287861;N-1H-pyrrolo[2,3-c]pyridin-5-ylbenzamide;N-(1H-pyrrolo[2,3-c]pyridin-5-yl)benzamide;C14H11N3O;BenzaMide, N-1H-pyrrolo[2,3-c]pyridin-5-yl-;N-{1H-pyrrolo[2,3-c]pyridin-5-yl}benzamide;Cambridge id 5236727;Oct4-activating Compound 1;TimTec1_006628;Oprea1_004689;Oprea1_365767;OAC 1; OAC-1;CHEMBL3187798;SCHEMBL15754799;AOB4083;EX-A905;HMS1552N06;HMS3653I19;ZINC289948;ALBB-027009;BCP21023;2571AH;s7217;AKOS000629693;CCG-266854;CS-4181;MCULE-1876478700;NCGC00347953-01;NCGC00347953-05;AK175746;AS-65742;HY-12303;FT-0700279;O0490;R3435;SW219832-1;N-1H-Pyrrolo[2,3-c]pyridin-5-ylbenz amide;J-017754",Epigenetic modulator
46853447,https://pubchem.ncbi.nlm.nih.gov/compound/46853447,P7C3-A20,,Neurogenic Modulator
19493,https://pubchem.ncbi.nlm.nih.gov/compound/19493,Parnate,"tranylcypromine;155-09-9;(1R,2S)-2-phenylcyclopropan-1-amine;Parnate;(1R,2S)-2-phenylcyclopropanamine;3721-26-4;Transamine;d-Tranylcypromine;l-Tranylcypromine;Cyclopropanamine, 2-phenyl-, trans-;(1r,2s)-rel-2-phenylcyclopropanamine;trans-2-Phenylcyclopropylamine;()-(R)-Tranylcypromine;95-62-5;Cyclopropanamine, 2-phenyl-, (1R,2S)-rel-;Jatrosom;trans-2-phenyl-cyclopropylamine;trans-(-)-2-Phenylcyclopropanamine;(1R,2S)-2-phenyl-cyclopropylamine;(1R,2S)-tranylcypromine;()-Tranylcypromine;(-)-Tranylcypromine;CHEMBL1179;Parnitene;AELCINSCMGFISI-DTWKUNHWSA-N;trans-2-phenylcyclopropanamine;2-Phenyl-1-aminocyclopropane, trans-;BRN 2802413;SKF Trans-385;Cyclopropylamine, 2-phenyl-, trans-(-)-;Cyclopropylamine, 2-phenyl-, (1S-trans)-;NSC 80664;Tranylcypromine [INN:BAN];Cyclopropanamine, 2-phenyl-, trans-(.�.)-;Cyclopropylamine, 2-phenyl-, trans-(.�.)-;Tranylcyprominum [INN-Latin];Tranilcipromina [INN-Spanish];CCRIS 3344;Cyclopropanamine, 2-phenyl-, trans-(+)-;HSDB 3404;Tranilcipromina;Tranylcyprominum;(1R)-1-Amino-2-phenylcyclopropane;EINECS 205-841-9;Parnate (Salt/Mix);BRN 3195803;SKF-trans-385;Cyclopropylamine, 2-phenyl-, trans-(+)-;(.�.)-Tranylcypromine;3721-28-6;trans-2-phenylcyclopropan-1-amine;Tranylcipromine;trans amine;trans-amine;(�)-trans-2-phenylcyclopropylamine;S-Tranylcypromine;(.�.)-trans-2-Phenylcyclopropamine;rel-Tranylcypromine;(.�.)-trans-2-Phenylcyclopropylamine;Prestwick0_000173;Prestwick1_000173;Prestwick2_000173;Lopac-P-8511;CBChromo1_000132;SCHEMBL34339;3-12-00-02797 (Beilstein Handbook Reference);Cyclopropanamine, 2-phenyl-, (1R-trans)- (9CI);SPBio_001986;trans-2-phenyl cyclopropylamine;(1R,2S)-trans-tranylcypromine;DTXSID2023694;(Trans)-2-phenylcyclopropanamine;[trans-2-phenylcyclopropyl]amine;CHEBI:94631;cid_2723716;CTK3G8797;CHEBI:131510;[(trans)-2-phenylcyclopropyl]amine;ZINC1482197;4694AJ;8372AH;BDBM50240772;FCH837207;PDSP2_001079;PDSP2_001080;(1R-trans)-2-phenyl-cyclopropanamine;AKOS006282586;(1R,2S)-2-phenyl-1-cyclopropanamine;FCH3609496;FCH4526577;NE64561;(1R,2S)-(-)-2-phenylcyclopropylamine;NCGC00015848-01;(tranylcypromine)2-Phenyl-cyclopropylamine;AC-15970;AK173621;LS-58822;LS-58823;(1R,2S)-rel-2-phenylcyclopropan-1-amine;Cyclopropanamine, 2-phenyl-, (1R-trans)-;CS-0008259;trans-(1R,2S)-2-Phenylcyclopropan-1-amine;EN300-197006;BRD-K47029922-003-03-4;UNII-3E3V44J4Z9 component AELCINSCMGFISI-DTWKUNHWSA-N;GJZ",Inhibitor of lysine-specific demethylase 1 (LSD1)
9826528,https://pubchem.ncbi.nlm.nih.gov/compound/9826528,PD0325901,"391210-10-9;PD0325901;PD 0325901;PD-0325901;(R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide;PD-325901;(R)-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE;PD 325901;UNII-86K0J5AK6M;N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;86K0J5AK6M;CHEMBL507361;CHEBI:88249;N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;Mirdametinib (USAN);Mirdametinib [USAN];NCGC00189075-01;391209-97-5;J-502503;C16H14F3IN2O4;N-((R)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide;PD325901;Mirdametinib;N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;SUDAHWBOROXANE-SECBINFHSA-N;4BM;PubChem22394;cc-61;DSSTox_CID_24024;DSSTox_RID_80100;mirdametinib (proposed INN);DSSTox_GSID_44024;870474-62-7;SCHEMBL172904;GTPL7935;DTXSID0044024;CTK8B5048;EX-A102;SYN1059;N-(2,3-Dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;N-{[(2S)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;BCPP000126;BDBM104963;HMS3648A14;AOB87344;ZINC3938683;Tox21_113364;ABP000920;ANW-47220;MFCD08435926;s1036;WHO 11299;AKOS015855518;BCP9001057;CCG-221316;CS-0062;DB07101;EX-8602;SB16502;KS-0000007I;N-[((R)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;NCGC00381744-09;BR-78415;HY-10254;US8575391, Q;AB0007877;AX8222618;A6561;BB 0261791;CAS-391210-10-9;FT-0673534;SW218101-2;W5947;D11675;S-7112;PD-0325901,PD325901;PD 0325901, >=98% (HPLC);PD-0325901/PD0325901;PD0325901 (PD325901);SR-01000946344;SR-01000946344-1;BRD-K49865102-001-01-9;Q27088255;(S)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide;Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-;Benzamide,N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-;N-((R)-2,3-Dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide",Inhibitor of MEK/ERK pathway
4708,https://pubchem.ncbi.nlm.nih.gov/compound/4708,PD168393,,Inhibitor of the EGFR
4369491,https://pubchem.ncbi.nlm.nih.gov/compound/4369491,PD407824,,Inhibitor of the checkpoint kinase 1 (CHK1)
27924,https://pubchem.ncbi.nlm.nih.gov/compound/27924,Phorbol 12-myristate 13-acetate,,_
37783,https://pubchem.ncbi.nlm.nih.gov/compound/37783,Phorbol dibutyrate,,Activator of the protein kinase C
4587369,https://pubchem.ncbi.nlm.nih.gov/compound/4587369,Pifithrin-α,"60477-38-5;Pifithrin-|A, p-Nitro, Cyclic;2-(4-nitrophenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole;Pifithrin-alpha, p-Nitro, Cyclic;p-nitro-Cyclic Pifithrin-|A;p-Nitro-CyclicPifithrin-alpha;CHEMBL180006;SCHEMBL5550051;KS-00003OR3;ZINC4025537;2-(4-Nitrophenyl)imidazo[2,1-b]-5,6,7,8-tetrahydrobenzothiazole;AKOS002999620;MCULE-2668343820;MS-2897;HY-123076;CS-0081157;SR-01000308695;SR-01000308695-1;4-(4-nitrophenyl)-7-thia-2,5-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,5-triene",Inhibitor of the p53
12003241,https://pubchem.ncbi.nlm.nih.gov/compound/12003241,Pluripotin,"Pluripotin;839707-37-8;N-(3-(7-(1,3-dimethyl-1H-pyrazol-5-ylamino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide;C27H25F3N8O2;SC1;Pluripotin (SC1);Stemolecule SC 1;SC1 (Pluripotin);MLS006010719;SCHEMBL3135215;CHEMBL4213673;Pluripotin, >=98% (HPLC);CTK5F1576;KS-00001CSZ;NBZFRTJWEIHFPF-UHFFFAOYSA-N;BCP02463;EX-A1260;s7752;ZINC38141704;AKOS024458159;CCG-270003;CS-5597;QC-8221;NCGC00167403-01;NCGC00167403-02;NCGC00167403-03;HY-10579;SMR004701683;X5707;N-(3-(7-((1,3-dimethyl-1H-pyrazol-5-yl)amino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide;N-[3-[7-[(1,3-Dimethyl-1H-pyrazol-5 -yl)amino]-1,4-dihydro-1-methyl-2-oxopyrimido[4,5- d]pyrimidin-3(2H)-yl]-4-methylphenyl]-3-(trifluoro methyl)benzamide;N-[3-[7-[(1,3-Dimethyl-1H-pyrazol-5-yl)amino]-1,4-dihydro-1-methyl-2-oxopyrimido[4,5-d]pyrimidin-3(2H)-yl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[3-[7-[(2,5-dimethylpyrazol-3-yl)amino]-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]-4-methylphenyl]-3-(trifluoromethyl)benzamide",Inhibitor of the RasGAP and ERK1
4878,https://pubchem.ncbi.nlm.nih.gov/compound/4878,PP2,,Activator of the SIRT1 and Inhibitor of the aminoresveratolsulfat and Src kinase
5280360,https://pubchem.ncbi.nlm.nih.gov/compound/5280360,Prostaglandin E2,,Modulator of the cAMP/PKA
44141940,https://pubchem.ncbi.nlm.nih.gov/compound/44141940,PS48,"1180676-32-7;PS48;PS 48;(Z)-5-(4-Chlorophenyl)-3-phenylpent-2-enoic acid;(2z)-5-(4-Chlorophenyl)-3-Phenylpent-2-Enoic Acid;CHEMBL539134;PS-48;5-(4-Chloro-phenyl)-3-phenyl-pent-2-enoic acid;(2Z)-5-(4-Chlorophenyl)-3-phenyl-2-pentenoic acid;SCHEMBL657791;SCHEMBL657792;EX-A383;LLJYFDRQFPQGNY-QINSGFPZSA-N;BCP08452;3981AH;BDBM50296949;MFCD17215962;ZINC42923782;AKOS024457972;CS-3364;PS48, >=98% (HPLC);HY-15967;QC-11434;B7586;3-Phenyl-5-(4-chlorophenyl)-2-pentenoic acid;A13484;(2Z)-5-(4-Chlorophenyl)-3-phenyl-2-pentenoicacid;(Z)-5-(4-Chlorophenyl)-3-phenylpent-2-enoicAcid;J-003699;Q27464270",Activator of the PDK1
44185871,https://pubchem.ncbi.nlm.nih.gov/compound/44185871,PSB603,,Antagonist of the A2B
1117196,https://pubchem.ncbi.nlm.nih.gov/compound/1117196,PTC-209,,Inhibitor of Bmi1
5284329,https://pubchem.ncbi.nlm.nih.gov/compound/5284329,Purmorphamine,"Purmorphamine;483367-10-8;2-(1-Naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine;UNII-PB12M2F8KY;PB12M2F8KY;CHEMBL1221984;CHEBI:63053;9-cyclohexyl-N-[4-(morpholin-4-yl)phenyl]-2-(naphthalen-1-yloxy)-9H-purin-6-amine;2-(1-Napthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine;9-Cyclohexyl-N-(4-(4-morpholinyl)phenyl)-2-(1-naphthalenyloxy)-9H-purin-6-amine;9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine;Purmorphamine [MI];Shh Signaling Antagonist VI;MolMap_000073;9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine;9H-Purin-6-amine, 9-cyclohexyl-N-(4-(4-morpholinyl)phenyl)-2-(1-naphthalenyloxy)-;cc-676;MLS006010334;SCHEMBL1548273;CTK1D4950;GTPL10356;KS-00000XPM;AOB5391;DTXSID20415293;EX-A348;FYBHCRQFSFYWPY-UHFFFAOYSA-N;HMS3650O20;HMS3651D16;BCP03687;BDBM50324671;HSCI1_000224;NSC747596;s3042;ZINC14806830;9-cyclohexyl-N-(4-morpholinophenyl)-2-(naphthalen-1-yloxy)-9H-purin-6-amine;AKOS024458218;CCG-269857;CS-1135;LS41103;NSC-747596;SB19498;NCGC00344053-01;NCGC00344053-09;4CA-1056;AK175828;AS-56474;DA-05531;HY-15108;QC-10453;SMR004701397;AB0032036;FT-0674154;SW219909-1;X5299;A11480;W-5393;SR-01000946316;J-519503;SR-01000946316-1;BRD-K73397362-001-01-7;Q15409344;9-cyclohexyl-N-[4-(morpholin-4-yl)phenyl]-2-(naphthalen-1-yloxy)-9H-purin-6 -amine;9-Cyclohexyl-N-[4-(morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine",Agonist of hedgehog
46223724,https://pubchem.ncbi.nlm.nih.gov/compound/46223724,Pyrintegrin,,Integrin activator
24794416,https://pubchem.ncbi.nlm.nih.gov/compound/24794416,QVD-OPH,,Inhibitor of the broad-spectrum caspase
449054,https://pubchem.ncbi.nlm.nih.gov/compound/449054,RepSox,"RepSox;446859-33-2;ALK5 Inhibitor II;2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine;SJN 2511;ALK5 Inhibitor;E-616452;GW786460X;CHEMBL185238;SJN-2511;C17H13N5;2-(3-(6-Methylpyridine-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine;2-[3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine;1vjy;TGF-beta RI Kinase Inhibitor II;Alk 5 Inhibitor II;PubChem24163;2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine;1,5-Naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-;cc-232;GW786460X (Repsox);MLS006011123;SCHEMBL144632;SCHEMBL16969100;CTK8E7448;RepSox, >=98% (HPLC);AOB1483;DTXSID80332295;LBPKYPYHDKKRFS-UHFFFAOYSA-N;HMS2043P13;HMS3261N03;HMS3653M19;BCP04103;EX-A2879;Tox21_500541;2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine;ABP000974;BDBM50151347;s7223;Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor II;ZINC16052804;AKOS016009677;BCP9000274;CCG-221845;CS-1321;NCGC00242054-01;NCGC00242054-02;NCGC00242054-03;NCGC00261226-01;4CA-1165;AC-28395;AK-35200;AS-16653;DA-42419;HY-13012;SC-96580;SMR004702903;BCP0726000102;AB0007897;AX8160241;FT-0759246;SW212662-2;X5942;J3.496.867E;W-5394;AB01092249-01;GW786460X (616452);E 616452;J-507645;2-[3-(6-Methyl-2-pyridyl)-1H-pyrazole-4-yl]-1,5-naphthyridine;2-[3-(6-Methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-[1,5]naphthyridine;E-616452;SJN 2511;E616452;SJN2511;E 616452;SJN-2511",Inhibitor of the ALK5 (TGF-β type 1 receptor)
444795,https://pubchem.ncbi.nlm.nih.gov/compound/444795,Retinoic acid,"Retinoic acid;tretinoin;302-79-4;Vitamin A acid;all-trans-Retinoic acid;trans-Retinoic acid;ATRA;Airol;Retin-A;Vesanoid;Renova;all-trans-Vitamin A acid;Dermairol;Aknoten;Aberel;Eudyna;All-trans Retinoic Acid;Aknefug;Cordes vas;Epi-aberel;Tretin M;Atralin;all-trans-Vitamin A1 acid;all-trans-Tretinoin;Retionic acid;All Trans Retinoic Acid;TRETINON;Vitamin A1 acid, all-trans-;Retin-A Micro;beta-Retinoic acid;all-(E)-Retinoic acid;Vitamin A acid, all-trans-;Effederm;Retinoic acid, all-trans-;Alltrans-retinoic acid;beta-Ra;Aberela [Norway];Avitoin [Norway];Acnavit [Denmark];Effederm [France];Retinoate;Retacnyl;Vesnaroid;NSC-122758;Ro 1-5488;A-Acido (Argentina);Tretinoin, all-trans-;all trans-Retinoic acid;Cordes VAS [Germany];Retin A;Stieva-A;A-Vitaminsyre [Denmark];(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;Tretinoine [INN-French];Tretinoinum [INN-Latin];Tretinoina [INN-Spanish];Tretinoino [INN-Spanish];Tretinoine;Solage;all-trans-beta-Retinoic acid;.beta.-Retinoic acid;Vitamin a acid, trans-;15-Apo-beta-caroten-15-oic acid;Acid A Vit (Belgium, Netherlands);UNII-5688UTC01R;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;CCRIS 3294;(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;MLS000028588;b-Retinoic acid;RETINOIC ACID, ALL TRANS;HSDB 2169;Tretinoin/All-Trans Retinoic Acid;AT-RA;CHEMBL38;(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid;2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-;EINECS 206-129-0;MFCD00001551;NSC122758;NSC 122758;BRN 2057223;Atragen;Retinova;SMR000058245;(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid;CHEBI:15367;SHGAZHPCJJPHSC-YCNIQYBTSA-N;5688UTC01R;Tretinoin (TN);AGN 100335;REA;9-cis-RA;Retin A (TN);NCGC00017280-10;Tretinoinum;Aberela;Acnavit;Avitoin;Betarretin;Tretinoina;Tretinoino;A-Vitaminsyre;all-trans-b-Retinoic acid;DSSTox_CID_1239;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL);3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-all-trans-tetraenoic acid;DSSTox_RID_76031;DSSTox_GSID_21239;trans-Retinoate;beta-Retinoate;all-trans-Retinoic acid, 97%;tretinoine (French) (EINECS);cis-Retinoic acid;Acide retinoique (French) (DSL);Refissa;Nexret;Avita Gel;Retisol-A;tretinoin liposome;4759-48-2;3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid;3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2E,4E,6E,8E-tetraenoic acid;(11Z)-retinoic acid;Tretinoin [USAN:INN:BAN];[3H]Retinoic acid;Renova (TN);Avita (TN);SR-01000000239;Tretinoin (Retinoic acid);Tretinoin (JAN/USP/INN);TNP00194;BML2-E05;1cbr;[3H]tretinoin;[All-E]-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;Tretinoin 0.1% cream or placebo;Tretinoin [USAN:USP:INN:BAN];(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aenoic acid;CAS-302-79-4;Prestwick_424;all-(E)-Retinoate;Tretinoine (French);Retinoic acid, cis-;(5E)-Retinoic acid;[3H]Vitamin A acid;PDT-002-002;PubChem16466;1n4h;CPD000058245;Retinoic acid all trans;6-s-trans-retinoic acid;Vitamin-A-sA currencyure;Opera_ID_1055;Prestwick2_000257;Prestwick3_000257;Spectrum5_001746;Spectrum5_001933;acide retinoique (French);Vesanoid (TN) (Roche);Tretinoin - Retinoic Acid;bmse000562;UPCMLD-DP097;R 2625;Renova (0.02% cream);SCHEMBL3145;(9Z,13Z)-Retinoic acid;Altreno (0.05% lotion);BIDD:PXR0081;Lopac0_001061;Avita (0.025% gel);BSPBio_000074;BSPBio_001500;MLS001076515;MLS002207234;MLS002222211;MLS002548861;MLS006010222;ARONIS25153;BIDD:GT0483;SPECTRUM1502016;9-cis-retinoic acid (9cRA);[3H]RA;BPBio1_000082;cid_444795;GTPL2644;.beta.-all-trans-Retinoic acid;all-trans-retinoic acid (ATRA);DTXSID7021239;SCHEMBL19091395;BDBM31883;HMS502N05;QCR-120;BCPP000036;BDBM323588;HMS1361K22;HMS1568D16;HMS1791K22;HMS1921D14;HMS1989K22;HMS2089D20;HMS2092N11;HMS2095D16;HMS2236N03;HMS3259E11;HMS3263E04;HMS3402K22;HMS3411B09;HMS3675B09;HMS3712D16;Pharmakon1600-01502016;Retinoic acid, all-trans- (8CI);ACT00012;BCP01405;Isotretinoin;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;US10188615, at-RA;Tox21_110812;Tox21_202330;Tox21_300305;Tox21_501061;All-trans Retinoic Acid (Tretinoin);CCG-39912;LMPR01090019;NSC759631;s1653;SBB065722;ZINC12358651;AKOS000280845;Tox21_110812_1;AB03039;AC-6824;CS-1269;DB00755;GS-3578;LP01061;LS-1154;NC00481;NSC-759631;SDCCGSBI-0051031.P004;IDI1_000903;IDI1_033970;NCGC00017280-05;NCGC00017280-06;NCGC00017280-07;NCGC00017280-08;NCGC00017280-09;NCGC00017280-12;NCGC00017280-15;NCGC00017280-16;NCGC00017280-17;NCGC00017280-18;NCGC00017280-19;NCGC00017280-20;NCGC00017280-23;NCGC00021808-04;NCGC00021808-05;NCGC00021808-06;NCGC00021808-07;NCGC00021808-09;NCGC00021808-11;NCGC00021808-14;NCGC00021808-15;NCGC00254179-01;NCGC00259879-01;NCGC00261746-01;trans-Retinoic acid|||Retinoid analogues;BP-20401;BR-73126;HY-14649;Retinoic acid, >=98% (HPLC), powder;SC-16932;ST057075;SBI-0051031.P003;EU-0101061;R0064;SW203749-4;02T794;5914-EP2275412A1;5914-EP2292576A2;A10944;C00777;D00094;J10054;Q29417;S-1635;33998-EP2275420A1;33998-EP2295055A2;33998-EP2295416A2;33998-EP2295426A1;33998-EP2295427A1;33998-EP2298748A2;33998-EP2298764A1;33998-EP2298765A1;33998-EP2298768A1;33998-EP2301928A1;33998-EP2305642A2;33998-EP2308833A2;33998-EP2308861A1;33998-EP2311453A1;33998-EP2311808A1;33998-EP2311829A1;33998-EP2311840A1;AB00052318-15;AB00052318-16;AB00052318-17;AB00052318_18;AB00052318_19;L000833;Q-200610;SR-01000000239-3;SR-01000000239-4;SR-01000000239-6;SR-01000000239-7;BRD-K06926592-001-01-7;BRD-K71879491-001-15-0;BRD-K71879491-001-22-6;SR-01000000239-12;SR-01000000239-13;SR-01000000239-14;SR-01000000239-15;WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1;Tretinoin, European Pharmacopoeia (EP) Reference Standard;WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1;Tretinoin, United States Pharmacopeia (USP) Reference Standard;3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;Tretinoin, Pharmaceutical Secondary Standard; Certified Reference Material;(2E,4E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoic acid;(4E,6E,8E)-9-(2,6,6-Trimethyl-1-cyclohexenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid;(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate;2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-;2,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2E,4E,6E,8E,-nonatetraenoic acid;all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid;(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid;2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)-;2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)--, (all trans)-;2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all trans)-;2,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-;3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid-, (all trans)-;97950-17-9",Agonist of a retinoic acid receptor
702558,https://pubchem.ncbi.nlm.nih.gov/compound/702558,RG108,"RG108;48208-26-0;N-Phthalyl-L-tryptophan;RG 108;RG-108;CHEMBL1564869;(S)-2-(1,3-dioxoisoindolin-2-yl)-3-(1H-indol-3-yl)propanoic acid;C19H14N2O4;(2S)-2-(1,3-dioxo-2-isoindolyl)-3-(1H-indol-3-yl)propanoic acid;NSC-401077;(s)-N-phthaloyltryptophan;NCIStruc1_001775;NCIStruc2_000834;SCHEMBL164192;2-(1,3-dioxoisoindolin-2-yl)-3-(1H-indol-3-yl)propanoic acid;CHEBI:95041;KS-00000XHZ;ZINC84613;AOB6949;BIR1004;SYN3037;ZX-AFC000944;HMS3651D15;RG 108,N-Phthalyl-L-tryptophan;BCP06930;EX-A2208;2683AH;BDBM50389497;BN0837;CCG-37087;MFCD08705332;NCGC00014891;NCI401077;s2821;AKOS024457533;API0010044;CS-1248;SB19339;NCGC00014891-02;NCGC00014891-03;NCGC00097992-01;HY-13642;AB0064932;P2023;SW219042-1;W-5383;BRD-K89391146-001-01-5;Q27166807",Inhibitor of the DNA methyltransferase
5092,https://pubchem.ncbi.nlm.nih.gov/compound/5092,Rolipram,,Inhibitor of the type 4 cyclic nucleotide phosphodiesterases (PDE4)
5352062,https://pubchem.ncbi.nlm.nih.gov/compound/5352062,Romidepsin,"Romidepsin;Istodax;FK228;Depsipeptide;Chromadax;Antibiotic FR 901228;FR901228;128517-07-7;FK 228;FK-228;FR 901228;FR-901228;NSC-630176;C24H36N4O6S2;CHEMBL343448;CHEBI:61080;NSC630176;NSC754143;UNII-CX3T89XQBK;NSC 630176;(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;Istodax (TN);CX3T89XQBK;HDInhib_000006;romidepsina;romidepsine;romidepsinum;OXA-12,8,20,23-TETRAZABICYCLO[8.7.6]TRICOSANE, CYCLIC PEPTIDE DERIV.;(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone;L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide;L-Valine, N-(3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aminobutanoyl-, xi-lactone, cyclic (1-2)-disulfide, (S-(E))-;FK-901228;Probes1_000153;Probes2_000337;Romidepsin (JAN/USAN/INN);SCHEMBL677497;GTPL7006;Romidepsin, >=98% (HPLC);BDBM19151;AOB1853;Romidepsin (FK228 ,depsipeptide);ZINC3935130;2692AH;s3020;API0005301;CS-0985;DB06176;NSC-754143;HY-15149;LS-161318;D06637;W-5757;49300-EP2298768A1;49300-EP2311840A1;AB01273968-01;SR-01000941579;Q7363205;SR-01000941579-1;L-Valine,3-didehydro-2- aminobutanoyl-,.xi.-lactone, cyclic (1.fwdarw.2)-disulfide;L-Valine,3-didehydro-2-aminobutanoyl-,.xi.-lactone, cyclic (1.fwdarw.2)-disulfide;(1S,4S,7Z,10S,16E,21R)-7- ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23- tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(E)-(1S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2- oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;(E)-(1S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2- oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone;Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"";Cyclo[(2Z)-2-amino-2-butenoyl-L-val yl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valy l-D-cysteinyl], cyclic (3-5) disulfide;Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3-5) disulfide",Inhibitor of the histone deacetylase
77999,https://pubchem.ncbi.nlm.nih.gov/compound/77999,Rosiglitazone,"rosiglitazone;122320-73-4;Avandia;Brl-49653;5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione;Rosiglizole;Brl 49653;rosiglitazone (Avandia);BRL49653;Avandaryl;TDZ 01;Rosiglitazone [INN:BAN];Avandamet;C18H19N3O3S;CHEBI:50122;Rosigilitazone;5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione;5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate;YASAKCUCGLMORW-UHFFFAOYSA-N;2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-;MFCD00871760;NCGC00095124-01;AK-72839;5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione;DSSTox_CID_17131;DSSTox_RID_79303;DSSTox_GSID_37131;Q-201681;5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione;5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione;2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-;CAS-122320-73-4;SR-01000763023;rosiglitazona;rosiglitazonum;Rosiglitazon;Rezult;Rosi;HSDB 7555;Rosiglitazone base;5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione;5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione;Gaudil (TN);Rosiglitazone (INN);Spectrum_001703;155141-29-0;Spectrum2_001241;Spectrum3_000997;Spectrum4_001125;Spectrum5_001464;SCHEMBL5169;BSPBio_002693;KBioGR_001609;KBioSS_002183;KSC914G9L;SPECTRUM1504263;SPBio_001142;GTPL1056;TDZ-01;DTXSID7037131;SCHEMBL14383595;CTK8B4395;KBio2_002183;KBio2_004751;KBio2_007319;KBio3_001913;KS-00000IPU;Rosiglitazone, >=98% (HPLC);HMS1922J11;HMS2094O13;HMS3649G08;HMS3656K16;HMS3744M11;HMS3871L03;Pharmakon1600-01504263;ACT04332;BCP03047;Tox21_111434;ANW-44906;BBL029079;BDBM50030474;BG0432;CCG-39102;GP6434;NSC758698;STL350047;AKOS015894872;Tox21_111434_1;AC-3459;API0006964;BCP9000017;CS-1088;DB00412;MCULE-8293284864;MP-0331;NSC-758698;SB17326;VA11695;2,4-Thiazolidinedione, 5-004-02-((((methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-;5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione;NCGC00095124-02;NCGC00095124-03;NCGC00095124-04;NCGC00095124-05;NCGC00095124-06;NCGC00095124-08;4CA-1110;BR-72839;CC-34292;HY-17386;SC-19017;SY031184;BCP0726000232;AB0011992;AX8017813;LS-151340;FT-0602578;R0106;S2556;SW197573-6;20R734;6P-065;D08491;J10213;S00306;AB00698473-15;AB00698473-17;AB00698473-18;AB00698473-19;AB00698473_20;AB00698473_21;AB00698473_22;AB00698473_23;C-20817;Q424771;SR-01000763023-5;SR-01000763023-6;BRD-A97437073-001-02-3;BRD-A97437073-001-03-1;BRD-A97437073-001-04-9;SR-01000763023-12;(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion;5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4dione;IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin);(�)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione;2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI);5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione;5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione;5-[[4-[2-(Methyl-2-pyridinylamino)e thoxy]phenyl]methyl]-2,4-thiazolidinedione;5-[[4-[2-(methyl-pyridin-2-ylamino)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione;5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione",Activator of the peroxisome proliferator-activated receptor gamma
5284330,https://pubchem.ncbi.nlm.nih.gov/compound/5284330,SAG,"912545-86-9;SAG;smoothened agonist;CHEMBL1221983;CHEMBL2160033;Smoothened Agonist (SAG) HCl;364590-63-6;C28H28ClN3OS;3-chloro-N-((1r,4r)-4-(methylamino)cyclohexyl)-N-(3-(pyridin-4-yl)benzyl)benzo[b]thiophene-2-carboxamide;3-Chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]methyl]benzo[b]thiophene-2-carboxamide;3-Chloro-N-(4-(methylamino)cyclohexyl)-N-(3-(pyridin-4-yl)benzyl)benzo[b]thiophene-2-carboxamide;N-(3-(Pyridin-4yl)benzyl)-3-chloro-N-(4-(trans-methylamino)cyclohexyl)benzo[b] thiophene-2-carboxamide;Smoothened Agonist (SAG);SAG free base;SAG dihydrochloride;sag (smo-agonist);SMO agonist (SAG);3-chloro-N-[4-(methylamino)cyclohexyl]-N-[(3-pyridin-4-ylphenyl)methyl]-1-benzothiophene-2-carboxamide;SAG1.3;SCHEMBL8437026;SCHEMBL10029769;SCHEMBL14707297;GTPL10327;DTXSID80415294;EX-A569;CHEBI:138438;912545-86-9(free base);BCP14694;KS-00001D1G;Smoothened Agonist (SAG) free base;4020AH;BDBM50393847;BDBM50393851;ZINC22066467;AKOS025142011;AKOS026750207;ZINC101549216;SAG dihydrochloride, >=98% (HPLC);compound 22 [PMID: 12391318];NCGC00347954-01;NCGC00384168-03;AS-35219;DA-40627;HY-12848;B5837;FT-0674498;Q15410188;3-chloro-N-[4-(methylamino)cyclohexyl]-N-{[3-(pyridin-4-yl)phenyl]methyl}-1-benzothiophene-2-carboxamide;3-Chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]methyl]benzo[b]thiophene-2-carboxamide dihydrochloride;3-chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[3-(pyridin-4-yl)benzyl]-1-benzothiophene-2-carboxamide;N-[4-(Methylamino)cyclohexyl]-N-[3-(4-pyridyl)benzyl]-3-chlorobenzo[b]thiophene-2-carboxamide",Agonist of the Smoothened
9858940,https://pubchem.ncbi.nlm.nih.gov/compound/9858940,SB-505124,,Inhibitor of TGF-b
11680113,https://pubchem.ncbi.nlm.nih.gov/compound/11680113,SB-736290,,Inhibitor of the MSK1
5169,https://pubchem.ncbi.nlm.nih.gov/compound/5169,SB202190,"SB 202190;152121-30-7;SB-202190;SB202190;FHPI;SB202190 (FHPI);UNII-PVX798P8GI;4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole;CHEBI:79090;4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole;Phenol, 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-;PVX798P8GI;C20H14FN3O;4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol;4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole;4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol;4-[5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl]phenol;4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol;4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl)phenol;4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]-1-cyclohexa-2,5-dienone;SMR001230795;SB 202190, Immobilized;InSolution&trade; SB 202190;Kinome_3708;Tocris-1264;BiomolKI_000051;Lopac-S-7067;biotinylated SB202190;BiomolKI2_000057;Lopac0_000173;BMK1-F3;BSPBio_001106;KBioGR_000446;KBioSS_000446;cc-468;MLS002153419;MLS006010258;SCHEMBL158854;CHEMBL278041;GTPL4307;SCHEMBL1230814;DTXSID7041120;BDBM13531;CHEBI:92952;KBio2_000446;KBio2_003014;KBio2_005582;KBio3_000831;KBio3_000832;AOB2557;EX-A313;SYN1073;4o77;ZX-AFC001670;Bio1_000479;Bio1_000968;Bio1_001457;Bio2_000393;Bio2_000873;HMS1362H07;HMS1792H07;HMS1990H07;HMS2235B15;HMS3229M22;HMS3244I13;HMS3244I14;HMS3244J13;HMS3260D07;HMS3267J19;HMS3371G22;HMS3403H07;HMS3412C22;HMS3654O15;HMS3674G07;HMS3676C22;BCP00675;Tox21_500173;ABP000229;BDBM50044784;BS0317;GK2422;MFCD00941964;s1077;ZINC14951176;ZINC89221712;AKOS005146403;AKOS026750414;ACN-053035;CCG-100655;CCG-204268;CS-0141;LP00173;QC-9800;SDCCGSBI-0050161.P003;4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one;IDI1_002148;SMP2_000191;NCGC00015962-01;NCGC00015962-02;NCGC00015962-03;NCGC00015962-04;NCGC00015962-05;NCGC00015962-06;NCGC00015962-07;NCGC00015962-08;NCGC00015962-09;NCGC00015962-10;NCGC00025089-01;NCGC00025089-02;NCGC00025089-03;NCGC00025089-04;NCGC00025089-05;NCGC00025089-06;NCGC00260858-01;AK-51368;AS-16228;HY-10295;SC-27980;LS-186973;LS-187615;EU-0100173;FT-0743934;SW218110-2;X7402;EC-000.2317;S 7067;SB 202190, >=98% (HPLC);SB 202190/SB-202190;121S307;SR-01000075720;SR-01000597393;J-513574;J-690315;SR-01000075720-1;SR-01000597393-1;BRD-K54330070-001-05-5;BRD-K54330070-001-07-1;Q27088696;Q27164687;4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-2H-imidazol;4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]-phenol;4-[4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazol-2-yl]phenol;4-[4-(4-Fluorphenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol;FHPI|||4-(4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol;4-[4-(4-fluorophenyl)-5-(4-pyridyl)-4-imidazolin-2-ylidene]cyclohexa-2,5-dien-1-one;2RE",Inhibitor of the p38
176155,https://pubchem.ncbi.nlm.nih.gov/compound/176155,SB203580,"152121-47-6;SB 203580;SB-203580;SB203580;4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine;4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine;RWJ 64809;4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole;4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole;CHEBI:90705;CHEMBL10;4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole;C21H16FN3OS;4-(4-(4-Fluorophenyl)-2-(4-(methylsulfinyl)-phenyl)-1H-imidazol-5-yl)pyridine;4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)pyridine;Pyridine, 4-(5-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)-;4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazol;4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine;4-[5-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-3H-imidazol-4-yl]pyridine;4-[5-(4-Fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine;4-{4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl}pyridine;PB 203580;SR-01000597367;1pme;InSolution&trade; SB 203580;Kinome_2521;Tocris-1202;Tocris-1402;cc-50;CBiol_001970;SCHEMBL95208;BSPBio_001104;MLS006010840;cid_176155;GTPL5269;DTXSID2040577;BDBM13336;CTK7C0221;CTK8E9223;AOB6367;BIS0733;EX-A134;SYN1074;4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE;CDMGBJANTYXAIV-UHFFFAOYSA-N;ZX-AFC000489;BCPP000074;BDBM192501;Bio1_000256;Bio1_000745;Bio1_001234;HMS1792H05;HMS1990H05;HMS3229O04;HMS3244I15;HMS3244I16;HMS3244J15;HMS3267B07;HMS3295M11;HMS3403H05;HMS3412M17;HMS3654M15;HMS3676M17;BCP01763;KS-000018EO;ABP000230;ANW-72176;BDBM50045333;BS0218;GK9716;MFCD00922198;s1076;AKOS005145971;AKOS015994568;AM81234;CCG-206878;CS-0140;ES-0013;SB16633;NCGC00025035-01;NCGC00025035-02;NCGC00025035-03;NCGC00025035-04;NCGC00025035-05;NCGC00381704-12;4CA-1136;AK-51369;HY-10256;QC-11773;SC-27890;SMR004701767;AB0033710;AX8150875;DB-026130;LS-186976;LS-187618;FT-0674525;SW218141-2;X7403;EC-000.2318;SB203580/SB-203580;K00038;S-7702;SB 203580, solid, >=98% (HPLC);SB 203580 & Z-100;121S476;J-008891;J-513573;Q7389023;SR-01000597367-1;4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-;BRD-A37704979-001-02-4;BRD-A37704979-003-01-2;SB203580,RWJ 64809,PB 203580;US9187470, 104 (SB203580);4-{4-(4-fluorophenyl)-2-[4-(methanesulfinyl)phenyl]-1H-imidazol-5-yl}pyridine;Pyridine, 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-;Pyridine, 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-yl]-;Pyridine, 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-yl]- & Z-100;RWJ-64809|||PB-203580|||4-[4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine",Inhibitor of the MAP kinase
4521392,https://pubchem.ncbi.nlm.nih.gov/compound/4521392,SB431542,"301836-41-9;SB-431542;SB 431542;4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide;SB431542;UNII-E1557V1V0N;4-[4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL]BENZAMIDE;CHEMBL440084;C22H16N4O3;E1557V1V0N;4-(4-(1,3-Benzodioxole-5-yl)-5-(2-pyridyl)-1H-imidazole-2-yl)benzamide;4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide;4-(5-benzo[1,3]dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)-benzamide;4-[5-(1,3-Benzodioxol-5-Yl)-4-(Pyridin-2-Yl)-1h-Imidazol-2-Yl]benzamide;Benzamide, 4-(4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl)-;SB-431542-A;SR-01000597591;3tzm;Benzamide, 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-;FHYUGAJXYORMHI-UHFFFAOYSA-N;Bio2_000852;Kinome_3428;PubChem22438;4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide hydrate;SB 431542 hydrate;J1.722.247C;BSPBio_001064;KBioGR_000404;KBioSS_000404;MLS006010130;SCHEMBL155156;GTPL8216;QCR-42;TB1614-GMP;DTXSID7042693;BCBcMAP01_000166;CHEBI:91108;cid_4521392;CTK8B8498;KBio2_000404;KBio2_002972;KBio2_005540;KBio3_000767;KBio3_000768;AOB6359;BIS4592;EX-A144;ZX-AFC000916;BCPP000076;Bio2_000372;HMS1362F05;HMS1792F05;HMS1990F05;HMS3268G21;HMS3403F05;HMS3412L21;HMS3648A08;HMS3654O13;HMS3676L21;ZINC603769;BCP01765;ABP000232;ANW-60468;BDBM50110208;CC-103;MFCD11045982;s1067;4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)-benzamide;4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide;AKOS016003159;AM81241;CCG-264802;CS-0135;SB19480;VZ27752;4-[4-(2H-1,3-benzodioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide;IDI1_002127;KS-000006B2;NCGC00025230-01;NCGC00025230-02;NCGC00025230-03;NCGC00025230-04;NCGC00025230-05;NCGC00025230-06;NCGC00025230-21;4CA-1141;AC-23169;AK-98838;AS-16946;HY-10431;SC-71212;SMR004701258;AB0033746;AX8150878;FT-0727008;SW212665-2;X7468;SB431542,SB-431542;A25496;S-7739;AB01092258-01;J-017814;J-514238;Q7388913;SR-01000597591-1;SR-01000597591-2;BRD-K67298865-001-02-5;4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide;4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1h-imidazol-2-yl]-benzamide;4-(5-(benzo[d][1,3]dioxol-5-yl)-4-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide;4-(5-Benzol[1,3]dioxol-5-yl-4-pyrldin-2-yl-1H-imidazol-2-yl)-benzamide hydrate;4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]-benzamide hydrate",Inhibitor of the Activin/BMP/TGF-β pathway
5186,https://pubchem.ncbi.nlm.nih.gov/compound/5186,Scriptaid,,Inhibitor of the HDAC
10316032,https://pubchem.ncbi.nlm.nih.gov/compound/10316032,SD-208,"SD-208;627536-09-8;SD 208;SD208;2-(5-chloro-2-fluorophenyl)-N-(pyridin-4-yl)pteridin-4-amine;CHEMBL238125;2-(5-chloro-2-fluorophenyl)-N-pyridin-4-ylpteridin-4-amine;2-(5-Chloro-2-fluorophenyl)pteridin-4-yl]pyridin-4-yl-amine;ALK5 Inhibitor V;[2-(5-Chloro-2-fluoro-phenyl)-pteridin-4-yl]-pyridin-4-yl-amine;SCI-208;C17H10ClFN6;MLS006010305;SCHEMBL411646;GTPL8246;DTXSID60438042;EX-A556;BERLXWPRSBJFHO-UHFFFAOYSA-N;2-(5-Chloro-2-fluorophenyl)-4-[(4-pyridyl)amino]pteridine;2-(5-Chloro-2-fluorophenyl)pteridin-4-yl)pyridin-4-yl amine;4-Pteridinamine, 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-;HMS3413H18;HMS3677H18;HMS3747G03;BCP02214;4032AH;ABP000300;BDBM50204834;MFCD11519969;s7624;Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor V;ZINC90485237;AKOS024457517;SD 208/SD-208;CCG-268059;CS-0895;SB19491;NCGC00165898-01;NCGC00165898-02;NCGC00165898-12;AK270131;AS-55881;HY-13227;SD-208, >=98% (HPLC), powder;SMR004701371;FT-0700345;EC-000.2447;A14066;W-5483;Q27088765;2-(5-chloro-2-fluorophenyl)-4-(4-pyridylamino)pteridine;4-Pteridinamine,2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-",Inhibitor of the TGF-b signalling
56962337,https://pubchem.ncbi.nlm.nih.gov/compound/56962337,SGC0946,"SGC0946;1561178-17-3;SGC 0946;SGC-0946;CHEMBL3087498;1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea;5-Bromo-7-{5-[(3-{[(4-Tert-Butylphenyl)carbamoyl]amino}propyl)(Propan-2-Yl)amino]-5-Deoxy-Beta-D-Ribofuranosyl}-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine;C28H40BrN7O4;MLS006011035;GTPL7020;SCHEMBL17433345;AOB3554;EX-A321;1-[3-[[(2R,3S,4R,5R)-5-(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl-propan-2-ylamino]propyl]-3-(4-tert-butylphenyl)urea;2714AH;BDBM50443016;s7079;ZINC97956664;AKOS024458211;CCG-270251;CS-3531;NCGC00344622-10;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-;HY-15650;SMR004702828;SGC0946, >=98% (HPLC);FT-0700220;SW219393-1;J-009275;Q27088790;1-[3-[[[(2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl](isopropyl)amino]propyl]-3-[4-(2,2-dimethylethyl)phenyl]urea;5-Bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-7H-pyrrolo[2,3-d]pyrimidin-4-amine;AW2",Inhibitor of the DOT1L methyltransferase
453216,https://pubchem.ncbi.nlm.nih.gov/compound/453216,SKF-86055,,Inhibirot of the ALK5
1560402,https://pubchem.ncbi.nlm.nih.gov/compound/1560402,SMER28,"SMER28;307538-42-7;SMER 28;N-Allyl-6-bromoquinazolin-4-amine;6-bromo-N-(prop-2-en-1-yl)quinazolin-4-amine;6-Bromo-N-2-propenyl-4-quinazolinamine;6-bromo-N-prop-2-enyl-4-quinazolinamine;CHEMBL494325;4-Quinazolinamine, 6-bromo-N-2-propen-1-yl-;C11H10BrN3;SMER-28;3srb;6-bromo-N-prop-2-enylquinazolin-4-amine;SMR000106755;CBMicro_021891;SMER26;Cambridge id 6164173;Oprea1_603374;MLS000110826;SMER-28;SMER 28;SCHEMBL13283266;CHEBI:93943;cid_1560402;CTK8E6903;KS-00000TKR;DTXSID10364408;4-(allylamino)-6-bromoquinazoline;HMS2384I08;HMS3263K19;SMER28 (2);BCP17486;EX-A1017;N-allyl-6-bromo-4-quinazolineamine;ZINC1766166;Tox21_501019;Allyl-(6-bromoquinazolin-4-yl)amine;BDBM50257750;CCG-14477;MFCD02166825;s8240;STK975188;AKOS002262854;SMER28, >99% (HPLC), solid;CS-5731;LP01019;MCULE-7864435735;SDCCGSBI-0021786.P002;NCGC00079175-02;NCGC00261704-01;AK541286;AS-65723;BCB03_000905;(6-bromoquinazolin-4-yl)prop-2-enylamine;BIM-0021786.P001;HY-100200;B7637;EU-0073802;M3106;ST50182394;PK04_181104;SR-01000453166;CU-01000047511-3;J-018126;SR-01000453166-1;BRD-K08478539-001-01-3;BRD-K08478539-001-02-1;Q27165697;28S",Enhancer of the mammalian autophagy
5222465,https://pubchem.ncbi.nlm.nih.gov/compound/5222465,Sodium butyrate,"SODIUM BUTYRATE;156-54-7;Sodium butanoate;Butanoic acid, sodium salt;Butyric acid sodium salt;Butyrate sodium;Sodium n-butyrate;Butyric acid, sodium salt;Sodium propanecarboxylate;Butanoic acid, sodium salt (1:1);Butanoic acid sodium salt;UNII-8RAS91C36W;CCRIS 7068;HSDB 5655;Sodium butyrate (USP);Sodium butyrate [USP];TPA/BA;EINECS 205-857-6;C4H7NaO2;MFCD00002816;NSC 174280;8RAS91C36W;CHEBI:64103;Butyric Acid, Na;Butyric acid sodium salt, 98%;CHEMBL62381;NSC174280;NSC-174280;NCGC00167555-01;Sodiumbutanoate;OR8783;Sodium butyrate, 98%;Tetradecanoyl phorbol acetate/ sodium butyrate;ACMC-209de2;DSSTox_CID_17672;DSSTox_RID_79352;DSSTox_GSID_37672;SCHEMBL30148;KSC491A0D;DTXSID3037672;CTK3J1001;HY-B0350A;KS-00000UYA;tetradecanoyl phorbol acetate (TPA)/ sodium butyrate (BA);MFBOGIVSZKQAPD-UHFFFAOYSA-M;HMS3650B09;ZX-AT008131;Tox21_112550;ANW-21624;s1999;Sodium butyrate, >=98.5% (GC);Sodium butyrate, >=99.0% (GC);AKOS003051490;AKOS015899795;CCG-266046;CS-3924;AK546578;AS-13929;CAS-156-54-7;LS-48173;FT-0660356;S0519;D08998;76625-EP2270008A1;76625-EP2281815A1;76625-EP2292593A2;76625-EP2292617A1;76625-EP2301934A1;76625-EP2305640A2;76625-EP2308868A1;AB01274751-01;Sodium butyrate, Vetec(TM) reagent grade, 99%;Q305004;Sodium butyrate, certified reference material, TraceCERT(R);Sodium butyrate, United States Pharmacopeia (USP) Reference Standard;Sodium butyrate, PharmaGrade, USP/NF, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.",Inhibitor of histone deacetylase
23662274,https://pubchem.ncbi.nlm.nih.gov/compound/23662274,Sodium pyruvate,,_
8515,https://pubchem.ncbi.nlm.nih.gov/compound/8515,SP600125,"129-56-6;1,9-Pyrazoloanthrone;SP600125;Pyrazolanthrone;Dibenzo[cd,g]indazol-6(2H)-one;Pyrazoleanthrone;SP 600125;Anthra[1,9-cd]pyrazol-6(2H)-one;SP-600125;Anthra-1,9-pyrazol-6-none;JNK Inhibitor II;2H-Dibenzo[cd,g]indazol-6-one;C.I. 70300;NSC 75890;ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE;UNII-1TW30Y2766;EINECS 204-955-6;BRN 0746890;CHEMBL7064;MLS002693964;CHEBI:90695;ACPOUJIDANTYHO-UHFFFAOYSA-N;1TW30Y2766;NCGC00015958-03;SAPK Inhibitor II;1pmv;SMR000015440;SR-01000075840;NSC75890;2zmd;InSolution&trade; JNK Inhibitor II;NSC-75890;Kinome_3844;Tocris-1496;BiomolKI_000068;Lopac-S-5567;BiomolKI2_000072;cid_8515;DSSTox_CID_20525;DSSTox_RID_79502;CBiol_002049;DSSTox_GSID_40525;Lopac0_000473;BMK1-G8;BSPBio_001066;ChemBiol10705 Compound 4;KBioGR_000406;KBioSS_000406;cc-622;JMC517015 Compound 2;KSC516G2D;MLS002153267;MLS006011577;SCHEMBL170980;anthra[1,9-cd]pyrazol-6-one;GTPL5273;CHEMBL1725279;DTXSID2040525;SCHEMBL15583517;BCBcMAP01_000053;BDBM16018;CTK4B6321;dibenz[cd,g]indazol-6(2h)-one;KBio2_000406;KBio2_002974;KBio2_005542;KBio3_000771;KBio3_000772;Bio1_000335;Bio1_000824;Bio1_001313;Bio2_000373;Bio2_000853;HMS1362F07;HMS1667K13;HMS1792F07;HMS1990F07;HMS2250C03;HMS3229I16;HMS3261O08;HMS3267P06;HMS3295M01;HMS3403F07;HMS3412F05;HMS3654P10;HMS3676F05;HMS3747M19;ALBB-024051;Anthra[1,9cd]pyrazol-6(2H)-one;BCP05457;EX-A1998;Tox21_110267;Tox21_500473;Anthra[1-9-cd]pyrazol-6(2H)-one;ANW-68872;BDBM50024294;BDBM50433916;CCG-47500;Dibenzo[cd,g]indazol-6(2H)-one #;HSCI1_000136;s1460;SBB000595;ZINC96298875;AKOS000115584;Anthrapyrazolone; 1,9-Pyrazoloanthrone;CCG-100672;CS-0196;DB01782;LP00473;MCULE-7820194475;SDCCGSBI-0050458.P003;VA10299;1,6-dihydrodibenzo[cd,g]indazol-6-one;2,6-dihydrodibenzo[cd,g]indazol-6-one;IDI1_002128;QTL1_000077;SMP2_000240;NCGC00015958-01;NCGC00015958-02;NCGC00015958-04;NCGC00015958-05;NCGC00015958-06;NCGC00015958-07;NCGC00015958-08;NCGC00025186-01;NCGC00025186-02;NCGC00025186-03;NCGC00025186-04;NCGC00025186-05;NCGC00261158-01;WLN: T C6665 1A P IV OMNJ;14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one;AK-57219;AS-14374;CAS-129-56-6;HY-12041;K914;LS-20607;SC-62298;SMR002530644;ST018684;DB-041928;EU-0100473;FT-0607068;SW218106-2;EN300-02083;Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100;K00068;S 5567;SP600125, >=98% (HPLC);AB00075935-01;SP 600125 & Z-100;129S566;Q4545713;SR-01000075840-1;SR-01000075840-2;SR-01000075840-4;SR-01000075840-6;SR-01000637108-1;W-108360;BRD-K01567962-001-04-0;BRD-K01567962-001-06-5;BRD-K01567962-001-08-1;BRD-K01567962-001-22-2;Z56785477;F1414-1245;14,15-diazatetracyclo[7.6.1.0(2),.0(1)(3),(1)]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one",Inhibitor of JNK
_,_,SP600625,,Inhibitor of the JNK
25093235,https://pubchem.ncbi.nlm.nih.gov/compound/25093235,SR-3677,"1072959-67-1;SR-3677;SR3677;N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide;N-[2-[2-(DIMETHYLAMINO)ETHOXY]-4-(1H-PYRAZOL-4-YL)PHENYL]-2,3-DIHYDRO-1,4-BENZODIOXIN-2-CARBOXAMIDE;SR 3677;N-{2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl}-2,3-dihydro-1,4-benzodioxine-2-carboxamide;JMC516642 Compound 5;SCHEMBL453528;CHEMBL521179;BDBM25474;DTXSID50648693;SYN1083;HMS3244C09;HMS3244C10;HMS3244D09;BCP01976;EX-A1752;3897AH;ABP000281;AKOS027422764;CS-1726;NCGC00345833-01;NCGC00345833-06;AS-16237;HY-13300;SR 3677/;DB-059617;FT-0726466;959D671;J-522791;N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide",Inhibitor of the ROCK-II
135456876,https://pubchem.ncbi.nlm.nih.gov/compound/135456876,STK081095,135456876,Putative Inhibitor of the Cyclooxygenase
2978770,https://pubchem.ncbi.nlm.nih.gov/compound/2978770,STK825882,2978770,Putative Inhibitor of the Cyclooxygenase
3823504,https://pubchem.ncbi.nlm.nih.gov/compound/3823504,STK833231,3823504,Putative Inhibitor of the Cyclooxygenase
5289418,https://pubchem.ncbi.nlm.nih.gov/compound/5289418,SU 5402,,"Inhibitor of VEGFR2, FGFR1, and PDGFRB"
5329150,https://pubchem.ncbi.nlm.nih.gov/compound/5329150,SU16F,"SU 16F;SU16f;251356-45-3;CHEMBL149201;5-[1,2-Dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid;SU-16F;3-substituted indolin-2-one 16f;BDBM4900;SCHEMBL4408682;ZINC3834020;AKOS015994588;ES-0059;NCGC00370874-01;HY-108628;CS-0029344;J-015830;(Z)-3-(2,4-dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;3-(2,4-dimethyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid;3-[2-[(2,3-Dihydro-6-phenyl-2-oxo-1H-indole-3-ylidene)methyl]-3,5-dimethyl-1H-pyrrole-4-yl]propanoic acid;5-[1,2-Dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl ]-2,4-dimethyl-1H-pyrrole-3-propanoic acid",Platelet-derived growth factor receptor (PDGFR)-β  inhibition
5289418,https://pubchem.ncbi.nlm.nih.gov/compound/5289418,SU5402,,"Inhibitor of the VEGFR2, FGFR1, and PDGFRB"
_,_,SVAK-12,,_
1123,https://pubchem.ncbi.nlm.nih.gov/compound/1123,Taurine,"taurine;2-aminoethanesulfonic acid;107-35-7;L-Taurine;tauphon;Ethanesulfonic acid, 2-amino-;2-Aminoethylsulfonic acid;O-Due;2-Sulfoethylamine;taufon;Aminoethanesulfonic acid;aminoethylsulfonic acid;2-aminoethane-1-sulfonic acid;beta-Aminoethylsulfonic acid;Taurinum [Latin];Taurina [Spanish];FEMA No. 3813;Taurine [INN];CCRIS 4721;UNII-1EQV5MLY3D;NCI-C60606;AI3-18307;NSC32428;EINECS 203-483-8;NSC 32428;1EQV5MLY3D;2-aminoethane sulfonic acid;.beta.-Aminoethylsulfonic acid;1-Aminoethane-2-sulfonic acid;CHEBI:15891;XOAAWQZATWQOTB-UHFFFAOYSA-N;MFCD00008197;NSC-32428;Taurine, 99%;NCGC00015997-06;DSSTox_CID_1304;DSSTox_RID_76069;DSSTox_GSID_21304;Taurine Hydrochloride;2-amino-ethanesulfonic acid;Taurina;Taurinum;CAS-107-35-7;SMR000326743;SR-01000076144;Taurine [USP:INN:BAN];C2H7NO3S;Taurineold;Taukard;HSDB 8167;Aminoethylsulfonate;Taurine,(S);Taurine (TN);b-Aminoethylsulfonate;Taurine (8CI);2-Aminoethylsulfonate;2-aminoethyl sulfonate;beta-Aminoethylsulfonate;PubChem18250;Tocris-0209;2aminoethanesulfonic acid;Taurine, >=99%;b-Aminoethylsulfonic acid;2-AminoethanesulfonicAcid;Lopac-T-0625;WLN: Z2SWQ;1-Aminoethane-2-sulfonate;ACMC-2098vs;bmse000120;bmse000805;bmse000863;EC 203-483-8;2-aminoethanesulfonic acid.;Lopac0_001134;SCHEMBL23068;Taurine, >=98%, FG;KSC178O6B;MLS000859681;MLS001332383;MLS001332384;ARONIS27193;Taurine (JP17/USP/INN);Aminoethylsulfonic acid (JAN);CHEMBL239243;GTPL2379;DTXSID3021304;CTK0H8760;KS-00000ADB;Taurine, >=99.0% (T);HMS2093L13;HMS2233D19;HMS3263D09;HMS3370J18;Pharmakon1600-01505463;HY-B0351;KS-000048OD;RKL10149;ZINC3809490;Tox21_110277;Tox21_202520;Tox21_501134;ANW-15782;BDBM50357220;LS-439;NSC759150;s2008;STL197941;AKOS005208848;Tox21_110277_1;CCG-205208;CS-2397;DB01956;Ethanesulfonic acid, 2-amino- (9CI);LP01134;MCULE-6041857208;NE10562;NSC-759150;SDCCGSBI-0051101.P003;Taurine, BioUltra, >=99.5% (T);Taurine, SAJ first grade, >=98.5%;NCGC00015997-01;NCGC00015997-02;NCGC00015997-03;NCGC00015997-04;NCGC00015997-05;NCGC00015997-07;NCGC00015997-08;NCGC00015997-10;NCGC00024497-01;NCGC00024497-02;NCGC00024497-03;NCGC00024497-04;NCGC00024497-05;NCGC00260069-01;NCGC00261819-01;AS-13587;I815;NCI60_002814;SC-19115;SBI-0051101.P002;Taurine, Vetec(TM) reagent grade, >=99%;A0295;AM20080018;B1846;EU-0101134;FT-0611241;T-130;C00245;D00047;T 0625;AB00443712-07;AB00443712_09;AB00443712_10;Q207051;J-508042;SR-01000076144-1;SR-01000076144-3;SR-01000076144-5;Taurine, certified reference material, TraceCERT(R);F2191-0280;Z1317839154;Taurine, cell culture tested, meets USP testing specifications;Taurine, United States Pharmacopeia (USP) Reference Standard;Taurine, Pharmaceutical Secondary Standard; Certified Reference Material;Taurine, PharmaGrade, Ajinomoto, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture",_
9848818,https://pubchem.ncbi.nlm.nih.gov/compound/9848818,Tauroursodeoxycholic acid,"Tauroursodeoxycholic acid;14605-22-2;TUDCA;Tauroursodeoxycholate;Taurolite;Ursodeoxycholyltaurine;UNII-60EUX8MN5X;Ursodeoxy cholic acid;UR 906;60EUX8MN5X;CHEMBL272427;CHEBI:80774;Sodium tauroursodeoxycholate;N-(3alpha,7beta-dihydroxy-5beta-cholan-24-oyl)-taurine;3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid N-(2-sulfoethyl)amide;2-[(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid;2-{[(3alpha,5beta,7alpha,8alpha,14beta,17alpha)-3,7-Dihydroxy-24-Oxocholan-24-Yl]amino}ethanesulfonic Acid;Tauroursodiol;Tauroursodeoxycholic acid (6CI,7CI);2-(((3-alpha,5-beta,7-beta)-3,7-Dihydroxy-24-oxocholan-24-yl)amino)ethanesulfonic acid;N-(3alpha,7beta-dihydroxy-5beta-cholan-24-oyl)taurine;TUDA;N-ursodeoxycholoyltaurine;Tauroursodesoxycholic acid;SCHEMBL40764;N-(3-alpha,7-beta-dihydroxy-5-beta-cholan-24-oyl)-Taurine;GTPL4746;Tauroursodeoxycholic acid;TUDCA;EX-A730;2-(((3-alpha,5-beta,7-beta)-3,7-Dihydroxy-24-oxocholan-24-yl) amino)ethanesulfonic acid;2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid;Ethanesulfonic acid, 2-(((3-alpha,5-beta,7-beta)-3,7-dihydroxy-24-oxocholan-24-yl)amino)-;ZINC3914813;BDBM50236230;LMST05040015;MFCD00065451;s3654;Sodium tauroursodeoxycholate, >=95%;CCG-269687;DB08834;HY-19696;SC-19467;CS-0016289;3alpha,7beta-dihydroxy-5beta-cholanoyltaurine;A-7558;C16868;605T222;A808445;Q7688907;Taurine, N-(3-alpha,7-beta-dihydroxy-5-beta-cholan-24-oyl)-, (8CI);2-[(3alpha,7beta-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonic acid;2-{[(3alpha,5beta,7beta)-3,7-dihydroxy-24-oxocholan-24-yl]amino}ethane-1-sulfonic acid;2-((R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid;2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid;2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-oxopentyl]amino]ethanesulfonic acid",Bile acid
46209426,https://pubchem.ncbi.nlm.nih.gov/compound/46209426,Thiazovivin,"Thiazovivin;1226056-71-8;N-benzyl-2-(pyrimidin-4-ylamino)thiazole-4-carboxamide;C15H13N5OS;N-benzyl-2-(pyrimidin-4-ylamino)-1,3-thiazole-4-carboxamide;N-Benzyl-2-(pyrimidin-4-ylamino)-thiazole-4-carboxamide;AK117147;SR-01000650935;PubChem24336;cc-22;MLS006011152;SCHEMBL669856;BIFK0055;CHEMBL3184878;CTK4B3173;KS-00000HNY;AOB2613;DTXSID00673091;HMS3654N10;EX-A1693;ABP000728;s1459;ZINC41739029;AKOS016010502;CCG-267592;CS-0468;QC-4348;NCGC00187983-01;NCGC00187983-10;4CA-1247;AC-28391;AS-16722;HY-13257;SC-45007;SMR004702926;AB0033840;AX8159850;FT-0675156;SW219580-1;X7616;W-5642;J-004834;SR-01000650935-1;SR-01000650935-2;N-Benzyl-[2-(pyrimidin-4-yl)amino]t hiazole-4-carboxamide;N-Benzyl-[2-(pyrimidin-4-yl)amino]thiazole-4-carboxamide;4-THIAZOLECARBOXAMIDE, N-(PHENYLMETHYL)-2-(4-PYRIMIDINYLAMINO)-;N-(PHENYLMETHYL)-2-(4-PYRIMIDINYLAMINO)-4-THIAZOLECARBOXAMIDE;TZV",Inhibitor of the RHO/ROCK pathway
19493,https://pubchem.ncbi.nlm.nih.gov/compound/19493,Tranylcypromine,"tranylcypromine;155-09-9;(1R,2S)-2-phenylcyclopropan-1-amine;Parnate;(1R,2S)-2-phenylcyclopropanamine;3721-26-4;Transamine;d-Tranylcypromine;l-Tranylcypromine;Cyclopropanamine, 2-phenyl-, trans-;(1r,2s)-rel-2-phenylcyclopropanamine;trans-2-Phenylcyclopropylamine;()-(R)-Tranylcypromine;95-62-5;Cyclopropanamine, 2-phenyl-, (1R,2S)-rel-;Jatrosom;trans-2-phenyl-cyclopropylamine;trans-(-)-2-Phenylcyclopropanamine;(1R,2S)-2-phenyl-cyclopropylamine;(1R,2S)-tranylcypromine;()-Tranylcypromine;(-)-Tranylcypromine;CHEMBL1179;Parnitene;AELCINSCMGFISI-DTWKUNHWSA-N;trans-2-phenylcyclopropanamine;2-Phenyl-1-aminocyclopropane, trans-;BRN 2802413;SKF Trans-385;Cyclopropylamine, 2-phenyl-, trans-(-)-;Cyclopropylamine, 2-phenyl-, (1S-trans)-;NSC 80664;Tranylcypromine [INN:BAN];Cyclopropanamine, 2-phenyl-, trans-(.�.)-;Cyclopropylamine, 2-phenyl-, trans-(.�.)-;Tranylcyprominum [INN-Latin];Tranilcipromina [INN-Spanish];CCRIS 3344;Cyclopropanamine, 2-phenyl-, trans-(+)-;HSDB 3404;Tranilcipromina;Tranylcyprominum;(1R)-1-Amino-2-phenylcyclopropane;EINECS 205-841-9;Parnate (Salt/Mix);BRN 3195803;SKF-trans-385;Cyclopropylamine, 2-phenyl-, trans-(+)-;(.�.)-Tranylcypromine;3721-28-6;trans-2-phenylcyclopropan-1-amine;Tranylcipromine;trans amine;trans-amine;(�)-trans-2-phenylcyclopropylamine;S-Tranylcypromine;(.�.)-trans-2-Phenylcyclopropamine;rel-Tranylcypromine;(.�.)-trans-2-Phenylcyclopropylamine;Prestwick0_000173;Prestwick1_000173;Prestwick2_000173;Lopac-P-8511;CBChromo1_000132;SCHEMBL34339;3-12-00-02797 (Beilstein Handbook Reference);Cyclopropanamine, 2-phenyl-, (1R-trans)- (9CI);SPBio_001986;trans-2-phenyl cyclopropylamine;(1R,2S)-trans-tranylcypromine;DTXSID2023694;(Trans)-2-phenylcyclopropanamine;[trans-2-phenylcyclopropyl]amine;CHEBI:94631;cid_2723716;CTK3G8797;CHEBI:131510;[(trans)-2-phenylcyclopropyl]amine;ZINC1482197;4694AJ;8372AH;BDBM50240772;FCH837207;PDSP2_001079;PDSP2_001080;(1R-trans)-2-phenyl-cyclopropanamine;AKOS006282586;(1R,2S)-2-phenyl-1-cyclopropanamine;FCH3609496;FCH4526577;NE64561;(1R,2S)-(-)-2-phenylcyclopropylamine;NCGC00015848-01;(tranylcypromine)2-Phenyl-cyclopropylamine;AC-15970;AK173621;LS-58822;LS-58823;(1R,2S)-rel-2-phenylcyclopropan-1-amine;Cyclopropanamine, 2-phenyl-, (1R-trans)-;CS-0008259;trans-(1R,2S)-2-Phenylcyclopropan-1-amine;EN300-197006;BRD-K47029922-003-03-4;UNII-3E3V44J4Z9 component AELCINSCMGFISI-DTWKUNHWSA-N;GJZ",Inhibitor of lysine-specific demethylase 1 (LSD1)
5546,https://pubchem.ncbi.nlm.nih.gov/compound/5546,Triamterene,,Inhibitor of the casein kinase 1 alpha
444732,https://pubchem.ncbi.nlm.nih.gov/compound/444732,Trichostatin A,"trichostatin A;58880-19-6;Trichostatin A (TSA);TSA;Trichostatin;Tricostatin A;UNII-3X2S926L3Z;Antibiotic A-300;(2E,4E,6R)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide;CHEBI:46024;C17H22N2O3;GNF-PF-1011;RTKIYFITIVXBLE-QEQCGCAPSA-N;3X2S926L3Z;A-300-I;2,4-Heptadienamide, 7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-;7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide;[R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide;Q-201864;(2E,4E,6R)-7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide;7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE;2,4-Heptadienamide, 7-(4-(dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-;2,4-Heptadienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-;TSN;trichostatine a;Trichlostatin A;Trichostatin(s);(2E,4E,6R)-7-(4-dimethylaminophenyl)-4,6-dimethyl-7-oxo-hepta-2,4-dienehydroxamic acid;(2E,4E,6R)-7-(4-Dimethylaminophenyl)-N-hydroxy-4,6-dimethyl-7-oxo-hepta-2,4-dienamide;Trichostatin A,TSA;Trichostatin A/TSA;(R)-Trichostatin A;NCGC_TSA;1c3r;3f0r;Trichostatin-A - TSA;A 300;SCHEMBL19886;cc-238;MLS006011095;SGCTO-002;SCHEMBL675951;GTPL7005;DTXSID6037063;CHEBI:93196;ZX-AFC000233;BCPP000035;HMS1362L09;HMS1792L09;HMS1990L09;HMS3403L09;HMS3649O20;BCP01776;EX-A1665;ABP000141;BDBM50005711;LMPK01000055;MFCD03848392;s1045;Trichostatin A from Streptomyces sp.;AKOS015899840;ZINC100014731;CCG-208142;CCG-208681;CS-0499;DB04297;SB17023;NCGC00162453-01;NCGC00162453-02;NCGC00162453-03;NCGC00162453-04;NCGC00162453-05;NCGC00162453-15;3C10;AS-74315;HY-15144;LS-74195;M984;SC-73346;SMR004702883;A8183;SW219664-1;M02571;W-5309;880T196;Q425894;SR-05000013796;SR-05000013796-3;BRD-K68202742-001-04-1;BRD-K68202742-001-05-8;Trichostatin A, >=98% (HPLC), from Streptomyces sp.;UNII-30RHG284Z4 component RTKIYFITIVXBLE-QEQCGCAPSA-N;Trichostatin A??, Vetec(TM) reagent grade, from Streptomyces sp., >=98%;(2E,4E,6R)-7-(4-(Dimethylamino)phen yl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamid e;(6R)-N-Hydroxy-4,6-dimethyl-7-oxo-7-[4-(dimethylamino)phenyl]-2,4-heptadienamide;7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6R-dimethyl-7-oxo-2E,4E-heptadienamide;2,4-Heptadienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)- (9CI);2,4-Heptadienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, [R-(E,E)]-;2,4-Heptadienamide,7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-",Inhibitor of the histone deacetylases I and II
5591,https://pubchem.ncbi.nlm.nih.gov/compound/5591,Troglitazone,,_
5289501,https://pubchem.ncbi.nlm.nih.gov/compound/5289501,TTNPB,"TTNPB;Arotinoid acid;71441-28-6;Arotinoic acid;Ro 13-7410;CCRIS 3297;TTNPB (Arotinoid Acid);AGN 191183;AGN-191183;UNII-673M8C29UR;4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid;BRN 2008247;CHEMBL275311;CHEBI:75261;673M8C29UR;(E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propen-1-yl)benzoic acid;4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid;(E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoic acid;p-((E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)propenyl)benzoic acid;4-[(1E)-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)PROP-1-ENYL]BENZOIC ACID;4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthenyl)-1E-propen-1-yl)benzoic acid;4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid;Benzoic acid, 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)-, (E)-;Tocris-0761;SR-01000076154;Lopac-T-3757;arotinoid Ro-137410;1xap;4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid;4-[2-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHENYL)-1E-PROPEN-1-YL]BENZOIC ACID;Ttnpb(arotinoid acid);Spectrum5_001943;DSSTox_CID_20743;DSSTox_GSID_40743;Lopac0_001176;BSPBio_001532;MLS002153338;SCHEMBL177444;BML2-E10;GTPL2646;DTXSID6040743;4-[2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-propenyl]-benzoic acid;FOIVPCKZDPCJJY-JQIJEIRASA-N;HMS1361M14;HMS1791M14;HMS1989M14;HMS2232G03;HMS3263L13;HMS3402M14;HMS3411H15;HMS3675H15;EX-A2171;ZINC4475360;Tox21_304044;Tox21_501176;BDBM50032219;MFCD00673917;s4627;AKOS024458636;CCG-205250;CS-3253;DB02877;LP01176;Ro-137410;SDCCGSBI-0051143.P002;(e)-4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid;(e)-4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl) benzoic acid;IDI1_034002;NCGC00016015-01;NCGC00016015-02;NCGC00016015-03;NCGC00016015-04;NCGC00016015-05;NCGC00016015-06;NCGC00016015-07;NCGC00016015-08;NCGC00016015-09;NCGC00016015-10;NCGC00024775-01;NCGC00024775-02;NCGC00024775-03;NCGC00024775-04;NCGC00024775-05;NCGC00024775-06;NCGC00024775-07;NCGC00024775-08;NCGC00261861-01;NCGC00357251-01;HY-15682;LS-38311;SMR001230750;CAS-71441-28-6;EU-0101176;Ro 13-7410;Arotinoid acid;AGN191183;SW219917-1;X6862;A13007;C15634;T 3757;102723-EP2272841A1;102723-EP2301936A1;102724-EP2272841A1;102724-EP2301936A1;SR-01000076154-1;SR-01000076154-3;SR-01000076154-5;BRD-K49685476-001-02-7;BRD-K49685476-001-05-0;Q27089031;(e)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-enyl)benzoic acid;4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-enyl)benzoic acid;p-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)propenyl]-benzoic acid;4-[(E)-2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-propenyl]-benzoic acid",Agonist of a retinoic acid receptor
46224516,https://pubchem.ncbi.nlm.nih.gov/compound/46224516,UNC0638,"UNC0638;1255580-76-7;UNC-0638;UNC 0638;2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine;UNII-26A103L2FO;CHEMBL1231795;26A103L2FO;2-Cyclohexyl-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine;2-cyclohexyl-6-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-7-[3-(pyrrolidin-1-yl)propoxy]quinazolin-4-amine;2-cyclohexyl-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-Cyclohexyl-6-Methoxy-N-[1-(1-Methylethyl)piperidin-4-Yl]-7-(3-Pyrrolidin-1-Ylpropoxy)quinazolin-4-Amine;2-Cyclohexyl-N-(1-isopropyl-4-piperidinyl)-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine;cc-643;MLS006010242;GTPL7015;SCHEMBL14844528;CHEBI:95074;AOB1616;DTXSID30154787;C30H47N5O2;HMS3426M09;HMS3743O07;BCP06142;EX-A2205;4142AH;BDBM50353128;s8071;ZINC58638344;AKOS024458105;CCG-208706;CS-2035;SB19045;NCGC00189220-01;NCGC00189220-03;NCGC00189220-05;4CA-1297;AK481257;AS-74910;HY-15273;SC-82798;SMR004701318;J-509244;Q27089086;2-cyclohexyl-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amin;4-Quinazolinamine, 2-cyclohexyl-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-",Inhibitor of the G9a and GLP histone methyltransferase
3121,https://pubchem.ncbi.nlm.nih.gov/compound/3121,Valproic Acid,"VALPROIC ACID;2-Propylpentanoic acid;99-66-1;2-Propylvaleric acid;Dipropylacetic acid;Depakine;Depakene;Valproate;Ergenyl;Di-n-propylacetic acid;Mylproin;Pentanoic acid, 2-propyl-;4-Heptanecarboxylic acid;n-Dipropylacetic acid;Propylvaleric acid;Myproic Acid;n-DPA;Dipropylacetate;Convulex;Depakin;Vupral;Di-n-propylessigsaure;Avugane;Baceca;Stavzor;Acido valproico;Kyselina 2-propylvalerova;Acide valproique;2-n-Propyl-n-valeric acid;Acidum valproicum;Acetic acid, dipropyl-;Abbott 44090;Valproinsaeure;Savicol;Depakine chrono;Depakin chrono;Valproic acid (USP);Acide valproique [INN-French];Acido valproico [INN-Spanish];Acidum valproicum [INN-Latin];2-PROPYL-PENTANOIC ACID;Di-n-propylessigsaure [German];Valeric acid, 2-propyl-;divalproex;Depakene (TN);Epilim;Kyselina 2-propylvalerova [Czech];2,2-di-n-propylacetic acid;Di-n-propylessigsaeure;UNII-614OI1Z5WI;NSC 93819;VPA;HSDB 3582;EINECS 202-777-3;MFCD00002672;CHEMBL109;(n-C3H7)2CHCOOH;BRN 1750447;AI3-10500;614OI1Z5WI;CHEBI:39867;NIJJYAXOARWZEE-UHFFFAOYSA-N;NSC-93819;Depakote CP;NCGC00091149-01;Convulsofin;Deproic;Alti-Valproic;Novo-Valproic;Penta-Valproic;Dom-Valproic;Med Valproic;Dipropyl Acetate;Nu-Valproic;DSSTox_CID_3733;DSSTox_RID_77171;DSSTox_GSID_23733;Valproic acid USP;PMS-Valproic Acid;2-Propylpentanoic acid, 99%;CAS-99-66-1;Depakote (TM);SMR000499581;Valproic acid [USAN:INN:BAN];2 PP (base);Valproic Acid, Sodium Salt (2:1);Valproinsyra;Novo-divalproex;Sandoz valproic;Dom-valproate;Gen-divalproex;Apo-valproic;A-44090;APO-divalproex;DOM-divalproex;Epival er;PHL-valproate;PMS-valproate;PMS-Divalproex;Erganyl; Stavzor;Dom-valproic acid;Apo-valproic syrup;PHL-valproic acid;Epiject I.V.;2-propyl-Pentanoate;Epical (TM);Epilim (Salt/Mix);Valproic acid [USAN:USP:INN:BAN];2-PropylpentanoicAcid;Depacon (Salt/Mix);Convulex (Salt/Mix);Eurekene (Salt/Mix);G2M-777;Valparin (Salt/Mix);Novo-Valproic - ECC;Spectrum_000521;Divalproex (Salt/Mix);Dom-valproic acid syrup;Ratio-Valproic - ECC;Valdisoval (Salt/Mix);ACMC-209sdq;2 -propylpentanoic acid;di-n-propyl acetic acid;S(-)-4-En-valproate;Spectrum2_000946;Spectrum3_001733;Spectrum4_000376;DOM-valproic acid E.C.;Heptane-4-carboxylic acid;PHL-valproic acid E.C.;PMS-valproic acid E.C.;Novo-valproic soft gel cap;EC 202-777-3;SCHEMBL2275;S-2-n-Propyl-4-pentenoate;(S)-2-propyl-4-pentanoate;KBioGR_000871;KBioGR_002277;KBioSS_001001;KBioSS_002278;KSC493G8T;MLS001076682;MLS001335927;MLS001335928;MLS002415770;BIDD:GT0858;DivK1c_000273;SPBio_000912;GTPL7009;DTXSID6023733;WLN: QVY3 & 3;CTK3J3389;KBio1_000273;KBio2_001001;KBio2_002277;KBio2_003569;KBio2_004845;KBio2_006137;KBio2_007413;KBio3_002626;KBio3_002757;KS-00000CCR;NIJJYAXOARWZEE-UHFFFAOYSA-;Valproic acid [USAN:BAN:INN];NINDS_000273;HMS2089J06;HMS2231E06;HMS3259C18;HMS3370C21;HMS3715B15;ACT05281;ALBB-032973;NSC93819;ZINC3008621;Tox21_111091;Tox21_201963;Tox21_300603;ANW-41052;BDBM50003616;LMFA01020291;s3944;SBB065764;STL445581;AKOS009156895;Tox21_111091_1;Valproic Acid 1.0 mg/ml in Methanol;CCG-221127;CS-1765;DB00313;LS-2068;MCULE-7136317196;NC00584;SDCCGSBI-0050864.P004;NCGC00091149-02;NCGC00091149-03;NCGC00091149-04;NCGC00091149-05;NCGC00091149-06;NCGC00091149-08;NCGC00091149-09;NCGC00162288-07;NCGC00254365-01;NCGC00259512-01;AK128830;AS-11354;HY-10585;SBI-0050864.P003;AB0009719;Depakote, Depacon,Valproic acid Sodium salt;LS-161170;791-EP2306789A1;FT-0609289;P0823;6400-EP1441224A2;6400-EP2272537A2;6400-EP2272827A1;6400-EP2275420A1;6400-EP2280008A2;6400-EP2298764A1;6400-EP2298765A1;6400-EP2308867A2;6400-EP2308870A2;6400-EP2311494A1;6400-EP2311840A1;6400-EP2314585A1;6400-EP2374790A1;A19450;C07185;D00399;AB00698315-06;Q240642;Q-200321;Sodium valproate; 2-Propylpentanoic acid sodium salt;SR-01000075242-7;F2191-0115;Z1511532065;Valproic acid, European Pharmacopoeia (EP) Reference Standard;Valproic acid, United States Pharmacopeia (USP) Reference Standard;InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10);Valproic acid for system suitability, European Pharmacopoeia (EP) Reference Standard;Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material;Valproic acid, Pharmaceutical Secondary Standard; Certified Reference Material",Inhibitor of histone deacetylase
54670067,https://pubchem.ncbi.nlm.nih.gov/compound/54670067,Vitamin C,"l-ascorbic acid;vitamin C;ascorbic acid;50-81-7;L()-Ascorbic acid;ascorbate;Cevitamic acid;Ascoltin;Ascorbicap;Natrascorb;Hybrin;Allercorb;Ascorbajen;Ascorbutina;Ascorteal;Cescorbat;Cetemican;Cevitamin;Citriscorb;Laroscorbine;Lemascorb;Proscorbin;Roscorbic;Secorbate;Testascorbic;Vitacimin;Vitamisin;Vitascorbol;Ascorin;Ascorvit;Cantaxin;Cebicure;Cebione;Cegiolan;Ceglion;Celaskon;Cemagyl;Cenetone;Cenolate;Cergona;Cetamid;Cevalin;Cevatine;Cevimin;Cevital;Cevitan;Cevitex;Colascor;Concemin;Redoxon;Vicelat;Viforcit;Viscorin;Vitacee;Vitacin;Adenex;Ascorb;Cantan;Cebid;Cebion;Cecon;Celin;Cemill;Cereon;Cevex;Ciamin;Cipca;Hicee;Ribena;Vitace;Xitix;L-ascorbate;Davitamon C;Arco-cee;Planavit C;Catavin C;Ce lent;Liqui-Cee;Vicomin C;Cee-Vite;Cevi-Bid;Scorbu-C;C-Level;C-Vimin;Cetane-Caps TD;Duoscorb;Scorbacid;Cewin;Antiscorbic vitamin;C-Long;C-Quin;C-Span;Meri-C;Cee-Caps TD;L-Lyxoascorbic acid;L-Xyloascorbic acid;Antiscorbutic vitamin;Cetane-Caps TC;3-Oxo-L-gulofuranolactone;Ce-Mi-Lin;IDO-C;Natrascorb injectable;CE-VI-Sol;Ferrous ascorbate;Acidum ascorbinicum;Ascor-B.I.D.;L-()-Ascorbic Acid;Acidum ascorbicum;Dora-C-500;Kyselina askorbova;3-Keto-L-gulofuranolactone;Ascorbicab;Cortalex;Ferancee;Stuartinic;Tolfrinic;Acido ascorbico;Acide ascorbique;Antiscorbutic factor;L-3-Ketothreohexuronic acid lactone;L-Threoascorbic acid;Chromagen;Kyselina askorbova [Czech];Caswell No. 061B;Vicin;Acide ascorbique [INN-French];Acido ascorbico [INN-Spanish];Acidum ascorbicum [INN-Latin];(R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one;NCI-C54808;L-threo-Hex-2-enonic acid, gamma-lactone;L-threo-Ascorbic acid;FEMA No. 2109;3-Oxo-L-gulofuranolactone (enol form);UNII-PQ6CK8PD0R;CCRIS 57;Cetebe;()-Ascorbic acid;HSDB 818;Hex-2-enonic acid gamma-lactone, L-threo-;EINECS 200-066-2;MFCD00064328;NSC 33832;Iron(II) ascorbate;PQ6CK8PD0R;component of E and C-Level;component of Endoglobin Forte;CHEBI:29073;component of Cortalex;component of Ferancee;NCGC00164357-01;E300;Magnorbin;(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one;DSSTox_CID_106;E-300;hex-1-enofuranos-3-ulose;Iron-ascorbic acid complexes;DSSTox_RID_75370;DSSTox_GSID_20106;Kangbingfeng;Chewcee;Citrovit;Juvamine;6730-29-6;Ceklin;Magnesium Ascorbicum;Vasc;L()-Ascorbic acid, 99%;()-Sodium L-ascorbate;Rovimix C;Scorbu C;cevibid;Ascorbinsaeure;Parentrovite;Sunkist;Ascorbic Acid, Monosodium Salt;Cell C;L()-Ascorbic acid, ACS reagent;roscorbi c;Acid Ascorbic;Viscorin 100M;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one;Ronotec 100;Suncoat VC 40;(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one;Oral Vitamin C;Rontex 100;ascor-b.i.d;Ascorbicap (TN);Xyloascorbic acid, L-;Ascoltin (TN);antiscorbic vita min;[14C]ascorbic acid;Ascorbic acid [BAN:INN:JAN];Ascorbic acid [INN:BAN:JAN];[14C]-ascorbic acid;ascorbic acid (vit C);L-Ascorbic acid, meets USP testing specifications;2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one;299-36-5;L-3-ketothreohexuronic acid;Cevitamate;ascorbic-acid;Ascor;L-lyxoascorbate;L-xyloascorbate;.Ascorbinsaure;L-AscorbicAcid;NSC-33832;Vitamin B mixture with vitamin C;3eka;cee-caps td;NSC-218455;Ester C;Ester-C;Sodium Ascorbate (Ascorbic Acid);()-ascorbate;L()-ascorbate;L-threo-hex-2-enono-1,4-lactone;AK-96407;L-Ascorbic acid, free radical form;L-()-ascorbate;Ascorbic acid [USP:INN:BAN:JAN];Ascorbic acid mixture with Vitamin B;Vitamin C,(S);E 300;PubChem18445;Ascorbic Acid DC97SF;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one;Prestwick3_000325;L-Ascorbic acid, 99%;Ascorbic Acid mixture with Vitamin B Complex;ASCOR (TN);SCHEMBL785;bmse000182;Vitamin C (Ascorbic acid);SCHEMBL4430;L-Ascorbic acid, FCC, FG;BSPBio_000329;(r)-5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5h-furan-2-one;KSC925A7P;MLS002153776;CHEMBL40274;BPBio1_000363;GTPL4532;GTPL4781;INS NO.300;L-Ascorbic acid, reagent grade;DTXSID5020106;L-Ascorbic acid, >=99.0%;CTK8C5077;BIA0602;DTXSID50986567;INS-300;Ascorbic acid (JP17/USP/INN);CIWBSHSKHKDKBQ-JLAZNSOCSA-N;ZX-AFC000785;HMS2096A11;HMS2231N16;HMS3713A11;(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one;89924-69-6;BCP27915;HY-B0166;KS-00000EU9;L-Threoascorbic acid,Antiscorbutic factor,Vitamin C;(R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one;Tox21_110315;Tox21_112104;Tox21_202127;Tox21_302958;ANW-73969;gamma-lactone L-threo-Hex-2-enonate;L-Ascorbic acid, analytical standard;L-Ascorbic acid, AR, >=99.5%;LS-145;s3114;AKOS016843589;Tox21_112104_1;ZINC100006770;ZINC100019304;CCG-207946;DB00126;FCH1121413;L-Ascorbic acid, mixt. with vitamin B;VIT0000113;gamma-lactone L-threo-Hex-2-enonic acid;L-Ascorbic acid, ACS reagent, >=99%;NCGC00091517-01;NCGC00091517-02;NCGC00091517-03;NCGC00091517-06;NCGC00188972-01;NCGC00256504-01;NCGC00259676-01;53262-66-1;BP-12831;SC-18563;SMR001233160;L-Ascorbic acid, plant cell culture tested;AB0010512;AX8021086;L-Ascorbic acid, reagent grade, crystalline;A0537;A8158;AB00376923;Ascorbic Acid (L-Ascorbic Acid; Vitamin C);SW198791-2;L-Ascorbic acid, BioUltra, >=99.5% (RT);L-Ascorbic acid, tested according to Ph.Eur.;3466-EP2269610A2;3466-EP2269978A2;3466-EP2269985A2;3466-EP2269988A2;3466-EP2269991A2;3466-EP2270000A1;3466-EP2270002A1;3466-EP2270008A1;3466-EP2270011A1;3466-EP2270505A1;3466-EP2272516A2;3466-EP2272537A2;3466-EP2272822A1;3466-EP2272834A1;3466-EP2272835A1;3466-EP2272844A1;3466-EP2275413A1;3466-EP2277848A1;3466-EP2277865A1;3466-EP2281823A2;3466-EP2284149A1;3466-EP2284150A2;3466-EP2284151A2;3466-EP2284152A2;3466-EP2284153A2;3466-EP2284155A2;3466-EP2284156A2;3466-EP2284164A2;3466-EP2284171A1;3466-EP2284178A2;3466-EP2284179A2;3466-EP2287140A2;3466-EP2287148A2;3466-EP2287150A2;3466-EP2287153A1;3466-EP2287156A1;3466-EP2289510A1;3466-EP2289883A1;3466-EP2289890A1;3466-EP2289892A1;3466-EP2292227A2;3466-EP2292228A1;3466-EP2292592A1;3466-EP2292612A2;3466-EP2292617A1;3466-EP2295055A2;3466-EP2295401A2;3466-EP2295409A1;3466-EP2295416A2;3466-EP2295419A2;3466-EP2295426A1;3466-EP2295427A1;3466-EP2295435A1;3466-EP2298735A1;3466-EP2298742A1;3466-EP2298748A2;3466-EP2298768A1;3466-EP2298770A1;3466-EP2298776A1;3466-EP2301536A1;3466-EP2301538A1;3466-EP2301929A1;3466-EP2301931A1;3466-EP2301935A1;3466-EP2301940A1;3466-EP2305219A1;3466-EP2305257A1;3466-EP2305636A1;3466-EP2305637A2;3466-EP2305648A1;3466-EP2305651A1;3466-EP2305668A1;3466-EP2305674A1;3466-EP2305679A1;3466-EP2305683A1;3466-EP2308854A1;3466-EP2308857A1;3466-EP2308861A1;3466-EP2308867A2;3466-EP2308870A2;3466-EP2311453A1;3466-EP2311455A1;3466-EP2311805A1;3466-EP2311807A1;3466-EP2311809A1;3466-EP2311824A1;3466-EP2311839A1;3466-EP2311842A2;3466-EP2314295A1;3466-EP2314584A1;3466-EP2314585A1;3466-EP2314588A1;3466-EP2314589A1;3466-EP2314590A1;3466-EP2314593A1;3466-EP2316452A1;3466-EP2316457A1;3466-EP2316458A1;3466-EP2316470A2;3466-EP2316825A1;3466-EP2316826A1;3466-EP2316827A1;3466-EP2316828A1;3466-EP2316832A1;3466-EP2316833A1;3466-EP2316837A1;3466-EP2374792A1;3466-EP2377510A1;3466-EP2380568A1;C 1000;C00072;D00018;L-Ascorbic acid, p.a., ACS reagent, 99.0%;93398-EP2380568A1;AB00376923_04;AB00376923_05;L-Ascorbic acid, JIS special grade, >=99.0%;L-Ascorbic acid, Vetec(TM) reagent grade, 99%;L-Ascorbic acid, BioXtra, >=99.0%, crystalline;Q199678;L-Ascorbic acid, puriss. p.a., >=99.0% (RT);Q27101942;47A605F0-4187-47A8-B0CE-F9E7DA1B0076;L-Ascorbic acid, p.a., ACS reagent, reag. ISO, 99.7%;Ascorbic acid, British Pharmacopoeia (BP) Reference Standard;Ascorbic acid, European Pharmacopoeia (EP) Reference Standard;L-Ascorbic acid, certified reference material, TraceCERT(R);L-Ascorbic acid, powder, cell culture tested, gamma-irradiated;3,4-Dihydroxy-5beta-[(S)-1,2-dihydroxyethyl]furan-2(5H)-one;Ascorbic acid, United States Pharmacopeia (USP) Reference Standard;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxy-2,3-dihydrofuran-3-one;(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one (non-preferred name);L-Ascorbic acid solution, 1.0 mg/mL in acetonitrile: water, certified reference material;L-Ascorbic acid, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%;L-Ascorbic acid, suitable for cell culture, suitable for plant cell culture, >=98%;178101-88-7;L-Ascorbic Acid (Vitamin C)-13C6 solution, 500 mug/mL in acetonitrile: water, certified reference material, ampule of 1 mL;L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.7-100.5% (oxidimetric);Valeryl fentanyl hydrochloride solution, 100 mug/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL",_
5280795,https://pubchem.ncbi.nlm.nih.gov/compound/5280795,Vitamin D3,,_
11210478,https://pubchem.ncbi.nlm.nih.gov/compound/11210478,WP 1066,,Inhibitor of the JAK2 and STAT3
135418940,https://pubchem.ncbi.nlm.nih.gov/compound/135418940,XAV939,"XAV-939;284028-89-3;XAV939;XAV 939;3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one;CHEBI:62878;C14H11F3N2OS;CHEMBL1086580;2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-ol;MFCD16879017;2-[4-(trifluoromethyl)phenyl]-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one;2-[4-(Trifluoromethyl)phenyl]-7,8-Dihydro-5h-Thiopyrano[4,3-D]pyrimidin-4-Ol;NVP-XAV-939;2-[4-(trifluoromethyl)phenyl]-7,8-dihydro-5H-thiino[4,3-d]pyrimidin-4-ol;NVP-XAV 939;XAV;3kr8;3uh4;Maybridge3_005018;cc-343;MLS006012021;SCHEMBL7783488;TB3748-GMP;SCHEMBL15315468;AOB4150;DTXSID60369423;XAV939,XAV-939;BCPP000009;HMS1445E02;HMS3414D07;HMS3648B17;HMS3654O16;HMS3678D07;HMS3743E05;BCP02128;EX-A1760;ABP000288;BDBM50188594;BDBM50318567;BS0283;s1180;ZINC13467799;AKOS015954858;AKOS024457786;AKOS026750243;CCG-208105;CS-0494;MCULE-6143908878;SB19432;IDI1_016405;KS-0000181U;NCGC00250397-01;NCGC00484998-01;AC-28393;AK198691;CS-10386;HY-15147;SC-95571;SMR003874205;XAV 939/XAV939,NVP-XAV939;XAV939, >=98% (HPLC);DB-067924;FT-0675873;SW218311-2;X7558;A25698;W-5666;SR-01000946403;J-511234;SR-01000946403-1;BRD-K12762134-001-01-3;BRD-K12762134-001-05-4;Q27132250;6,8-Dihydro-2-[4-(trifluoromethyl)phenyl]-5H-thiopyrano[3,4-d]pyrimidine;2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one;2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-3H-thiopyrano[4,3-d]pyrimidin-4(5H)-one;2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano-[4,3-d]pyrimidin-4-ol;2-(4-Trifluoromethyl-phenyl)-3,5,7,8-tetrahydro-thiopyrano[4,3-d]pyrimidin-4-one;2-[4-(Trifluoromethyl)phenyl]-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one;2-[4-(trifluoromethyl)phenyl]-1H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one;NVP-XAV939;3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one",Inhibitor of the WNT/β-catenin signaling
1893730,https://pubchem.ncbi.nlm.nih.gov/compound/1893730,XL147,,Inhibitor of PI3 kinase
448042,https://pubchem.ncbi.nlm.nih.gov/compound/448042,Y-27632,"y-27632;146986-50-7;Y27632;Y 27632;UNII-0X370ROP6H;cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans-;4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide;0X370ROP6H;CHEBI:75393;(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE;(R)-()-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide;Y27;(R)-Trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide;2etr;2gnf;2gnj;1q8t;(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide dihydrochloride;(R)-()-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide dihydrochloride;BiomolKI_000071;BiomolKI2_000075;Y-27632, free base;CBiol_001962;BSPBio_001234;KBioGR_000574;KBioSS_000574;521059-79-0;SCHEMBL598993;CHEMBL559147;GTPL5290;ROCK Inhibitor, Y-27632;SCHEMBL1980406;SCHEMBL7804373;ZINC6989;CHEMBL1083134;CHEMBL1188380;DTXSID7043740;SCHEMBL13970844;SCHEMBL18935698;BDBM14029;BDBM86729;CHEBI:92773;KBio2_000574;KBio2_003142;KBio2_005710;KBio3_001027;KBio3_001028;4-[(1R)-1-aminoethyl]-N-(4-pyridyl)cyclohexanecarboxamide;BCPP000008;Bio1_000248;Bio1_000737;Bio1_001226;Bio2_000457;Bio2_000937;HMS1362N15;HMS1792N15;HMS1990N15;HMS3403N15;4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide;BDBM50319631;(1R,4r)-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide;AKOS026750241;AKOS028109253;ZINC100002002;ZINC252286763;AM81233;CCG-204428;CS-0131;DB08756;SB19471;IDI1_002212;SMP2_000199;NCGC00092276-02;NCGC00092276-03;NCGC00092276-04;NCGC00092276-05;NCGC00092276-06;NCGC00092276-07;NCGC00092276-08;NCGC00092276-09;NCGC00092276-10;HY-10071;LS-191400;CAS_146986-50-7;FT-0601668;A25646;S-7699;J-008296;J-525164;Q6584634;BRD-K44084986-001-03-9;BRD-K44084986-300-02-7;(R)-4-(1-Aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide;trans-4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexanecarboxamide;trans-4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexanecarboxamide;(R)-()-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide;[]-[R]-trans-4-[1-aminoethyl]-N-[4-pyridyl]cyclohexanecarboxamide;Cyclohexanecarboxamide, 4-(1-aminoethyl)-N-4-pyridinyl-, [4(R)-trans]-;Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI);trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecar boxamide dihydrochloride",Inhibitor of ROCK1 and ROCK2
100016,https://pubchem.ncbi.nlm.nih.gov/compound/100016,Zebularine,,Inhibitor of the DNA methyltransferase
5727,https://pubchem.ncbi.nlm.nih.gov/compound/5727,Zinc chloride,,_
5730,https://pubchem.ncbi.nlm.nih.gov/compound/5730,ZM33637,,Activator of Raf-1
1567,https://pubchem.ncbi.nlm.nih.gov/compound/1567,β-mercaptoethanol,,_
_,_,N-hydroxy-2-oxo-3-(3-phenylprophyl)-1'2-dihydroquinoxaline-6-carboxamide,,_
2814138,https://pubchem.ncbi.nlm.nih.gov/compound/2814138,OAC2,,_
5282411,https://pubchem.ncbi.nlm.nih.gov/compound/5282411,Prostaglandin I2,,"Activator of prostaglandin receptors EP1, EP2, EP3 and EP4"
10202642,https://pubchem.ncbi.nlm.nih.gov/compound/10202642,GW788388,,Inhibitor of Transforming Growth Factor Beta Signaling
6437836,https://pubchem.ncbi.nlm.nih.gov/compound/6437836,Peretinoin,,Agonist of retinoid acid receptor (RAR)
1613,https://pubchem.ncbi.nlm.nih.gov/compound/1613,Zopolrestat,,Inhibitor of carboxylic acid aldose reductase